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ABSTRACT 
Trafficking of Integral Membrane Proteins of the Inner Nuclear Membrane Can  
 
Be Mediated by the “Sorting Motif” of Autographa californica  
 
Nucleopolyhedrovirus ODV-E66.  (August 2005) 
 
Shawn T. Williamson, B.S., Texas A&M University 
 
Chair of Advisory Committee:  Dr. Max D. Summers 
 
 
The amino-terminal 33 amino acids of the baculovirus integral membrane 
protein, ODV-E66, are sufficient for localization of fusion proteins to viral-
induced intranuclear microvesicles (MV) and occlusion derived virus envelopes 
during infection, and has been termed the sorting motif (SM).  When abundantly 
expressed, SM-fusions are also detected in the inner nuclear membrane (INM), 
outer nuclear membrane and endoplasmic reticulum of infected cells, suggesting 
proteins with the SM use the same trafficking pathway as cellular INM proteins 
to traffic to nuclear membranes.  This study identifies the essential 
characteristics required for sorting of the SM to the INM of uninfected cells, and 
the MV and ODV envelopes of infected cells.  These features are an 18 amino 
acid transmembrane sequence that lacks polar and charged amino acids (a.a.) 
with a cluster of charged a.a. spaced 5-11 residues from the end of the 
transmembrane sequence.  A comparison of the a.a. sequence of these SM 
features with cellular INM proteins shows the features are conserved. 
The model of INM protein sorting and localization predicts the only known 
sorting event during INM protein trafficking is immobilization/retention in the INM.   
iv 
This study uses confocal microscopy and fluorescence recovery after 
photobleaching to compare the localization and mobility of lamin B receptor 
(LBR) fusions (which contain SM-like sequences) to a viral SM fusion when 
expressed in either mammalian or insect cells.  The results show that 
immobilization is not necessarily required for accumulation of proteins in the 
INM.  Furthermore, the results from infected cells show that an active sorting 
event, likely independent of immobilization, can distinguish the viral SM from 
cellular sequences similar to the SM. 
The results of this study show that sorting of proteins to the INM can be 
mediated by the viral SM or INM protein SM-like sequences that can function 
either independent of, or in addition to, immobilization.  These data combined 
with recent reports suggest that in addition to diffusion:retention a signal 
mediated mechanism for sorting and localization to the INM can occur. 
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INTRODUCTION 
Literature review 
Baculovirus: General information, hosts and infection process.  The 
Baculoviridae are a family of viruses with single or multiple enveloped rod-
shaped nucleocapsids containing a circular, double stranded DNA genome 
ranging from 82 kb pairs [NeleNPV, (1)] to 179 kb pairs [XcGV, (2)] in length.  
They are classified into two types based on the type of viral occlusion formed 
during infection, granulovirus (GV) and nucleopolyhedrovirus (NPV).  NPV is 
further classified into two subgroups, group I and II NPV, based on phylogentic 
data (3-5).  Baculovirus is characterized by an unusual biphasic lifecycle that 
results in the production of two forms of progeny virus, budded virus (BV) and 
occlusion derived virus (ODV), both of which are essential for natural infection 
(6).  The ODV form matures in the nucleus and is encapsulated in crystalline 
protein matrix structures termed viral occlusions.  Infection is initiated when the 
viral occlusions are consumed by a susceptible larval host (7).  Upon 
consumption, the occlusions are dissolved by the high pH of the insect midgut, 
releasing the enveloped ODV.  ODV enters the cell by fusion of the ODV 
envelope with the microvilli of the gut cell epithelium, and infection initiates in the 
nucleus of the columnar cells (8-10).  Early in infection, progeny nucleocapsids 
assemble in the nucleus and then transport to the basolateral plasma membrane 
_______________ 
This dissertation follows the style and format of Traffic. 
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where they are enveloped and bud into the insect hemolymph as budded virus.  
BV is responsible for secondary infection throughout the remaining tissues of the 
larvae, by distribution in the hemolymph and through the tracheal system (11, 
12).  Alternatively, Granados et al. (7) observed nucleocapsids budding from the 
basolateral membrane prior to the production of BV (as early as 0.5 h p.i.).  This 
observation suggests that parental ODV nucleocapsids are capable of directly 
initiating secondary or systemic infection of the host (7).  As primary infection 
progresses the midgut cells die and are sloughed off.  Secondary infection is 
initiated as BV infects the remaining cells of the insect.  During secondary 
infection BV is also produced, however, during the later stages of infection 
nucleocapsids remain in the nucleus where they are enveloped forming ODV.  
The ODV form of the virus is occluded in a crystalline protein matrix, while in the 
nucleus [polyhedra (NPV)] or in the cytoplasm [granule (GV)] (6, 13).  The major 
structural protein of NPV occlusions (polyhedra) is polyhedron and of GV 
occlusion (granule) is granulin.  NPV occlusions may contain one to many 
virions, whereas GV occlusions only contain a single virion.  As infection 
progresses, the insect host dies and upon death the larva liquefies.  This 
liquefaction results in the release and spread of the viral occlusions into the 
surrounding environment ensuring transmission of virus among insect hosts (6).   
 To date over 500 NPV have been identified and isolated exclusively from 
arthropods (14), primarily from the order Lepidoptera, but also from 
Hymenoptera, Diptera, Coleoptera, Neuroptera, Thysanura, Trichoptera and the 
3 
crustacean order Decapoda (shrimp).  GV have only been isolated from 
arthropods in the order Lepidoptera (6).  In general, the baculoviruses have a 
limited host range, often only infecting one species of insect, however, some 
have been shown to have a broader host range but are limited to single order.   
Autographa californica multi-nucleopolyhedrovirus, AcMNPV (type 
species), is the baculovirus used in this study.  Unlike most baculoviruses, 
AcMNPV infects over 30 different species of insects in 12 families of the order 
Lepidoptera.  Because AcMNPV has a large host range, it has been extensively 
studied as a “viral pesticide” (14).  Additionally, AcMNPV was used in the 
development of the baculovirus expression vector system (15, 16).  AcMNPV is 
also considered an important model system for the study of the molecular 
biology of baculovirus infection as it is easily studied in cultured cell systems 
(14). 
Baculovirus: Genome organization, DNA replication and gene regulation 
genome organization.  AcMNPV has a circular, double stranded DNA genome 
of 133,894 bp.  The genome sequence of AcMNPV (strain C6), the first 
baculovirus to be sequenced and annotated, was completed in 1994, and is 
comprised of 154 potential open reading frames (17).  To date a total of 18 
baculovirus genomes have been sequenced, including five GV (2, 18-21), ten 
Lepidopteran NPVs (17, 22-30), two Hymenopteran NPVs (1, 31), and one 
Dipteran NPV (32).  Comparison of the sequenced genomes determined that 29 
genes are common to all baculoviruses.  Of these 29 genes, 20 have known 
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Gene Function Genes present in all 
baculoviruses 
Additional genes conserved in 
lepidopteran baculoviruses 
   
Replication lef-1(ac14), lef-2(ac6), dna 
pol(ac65), helicase(ac95) 
dbp1(ac25), lef-3(ac67), IE-
1(ac147), me53(ac139) 
 
Transcription p47(ac40), lef-8(ac50), lef-
9(ac62), vlf-1(ac77), lef-4(ac90), 
lef-5(ac99) 
 
Pp31/39k(ac36), lef-6(ac28), lef-
11(ac37) 
Structural proteins ac23(ld130)(not in NeleNPV), 
gp41(ac80), odv-ec27(ac144), 
odv-e56(ac148), p6.9(ac100), 
p74(ac138), vp91/p95(ac83), 
vp39(ac39), vp1054(ac54) 
 
FP25K(ac61), odv-e18(ac143), 
odv-e25(ac94), odv-e66(ac46), 
pk1(ac10), polh(ac8) 
Auxiliary  alk-exo(ac133) 
 
fgf(ac32), ubiquitin(ac135) 
Unknown 38k(ac98), ac22, ac68, ac81, 
ac92, ac96, ac109, ac115, ac119, 
ac142 
38.7k(ac13), ac29, ac38, ac53, 
ac66, ac75, ac76, ac78, ac82, 
ac93, ac106, ac110, ac145, 
ac146, p40(ac101), p12(ac102), 
p45(ac103) 
Adapted from Herniou, et al., (2003)(33) and Lauzon, et al., (2004)(1) 
 
functions, and include genes responsible for DNA replication and transcription 
as well as genes that encode structural proteins.  In Lepidopteran baculoviruses 
an additional 32 genes, of known and unknown function, are conserved (33) 
[see Table 1 for summary of conserved baculovirus genes (1, 33)].  Some of the 
differences in genomic composition among the baculovirus strains are attributed 
to the acquisition of DNA sequences from the host cell and/or other viruses. It is 
speculated that baculoviruses have acquired host cell genes to gain selective 
advantages such as an increase in virulence or host range (34).   
 Viral DNA replication.  AcMNPV DNA replication occurs in the host cell 
nucleus, utilizing both cellular and virus encoded replication machinery.  
Table 1.  Genes conserved in the baculoviruses 
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Replication is detected as early as 6 h p.i. (hours post infection) (35) and 
continues through 18 h p.i. with the viral DNA content doubling every 1.7 hours 
until budding of BV begins, after which the rate of synthesis declines (36, 37).  
Using an in vitro DNA replication system, six viral proteins are identified and 
required for viral DNA replication: helicase, DNA polymerase, IE-1, Lef-1, Lef-2, 
and Lef-3 (38).  Additionally, 3 other proteins stimulate DNA replication, but are 
not essential: p35, Ie-2, PE-38.  Five of the proteins required for replication (all 
except Lef-2) are identified structural proteins of the ODV, indicating the virus 
may be able to initiate DNA replication at the time of infection (39).  Additionally, 
four of the six genes encoding the essential DNA replication machinery are 
conserved among the sequenced baculoviruses (Table 1) (33).  Replication 
origins within the genome sequence of AcMNPV and OpMNPV are within the 
homologous repeat regions, however, several non-homologous repeat regions 
can also act as replication origins in AcMNPV and other baculoviruses (40, 41). 
Regulation of viral gene expression.  Baculovirus genes are temporally 
expressed and are divided into one of four classes: immediate early, delayed 
early, late and very late genes (42). 
Early baculovirus gene expression:  Purified viral DNA transfected into 
the host cell in vitro can initiate infection, thus virus encoded transcription factors 
are not required to initiate infection (43).  Baculovirus early genes are 
transcribed prior to viral DNA replication (6 h p.i.) and are transcribed by the host 
cell RNA polymerase II (44, 45).  These genes encode the proteins required for 
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viral DNA replication and transcription factors needed for late and very late gene 
expression (46, 47).  The early genes are classified as either immediate early or 
delayed early.  Five immediate early genes have been identified: IE-0 and IE-1 
(48-56), IE-2 (57-61), PE-38 (61-63), and ME-53 (64, 65).  The immediate early 
transcription consensus sequence, TATAtAa-(N)19T-(N)4-CAGT, was identified 
from the comparison of five baculovirus early genes (66).  Several upstream 
regulatory sequences are required for transcription activation including the TATA 
box (43, 67), and the GATA motif (68, 69).  Delayed early genes require IE1 for 
transcription (49), but have a similar transcription start sequence as the 
immediate early genes.  In addition to the early transcription consensus 
sequence, homologous regions within the genome can also act as enhancers of 
transcription (49, 70).   
Late baculovirus gene expression:  The baculovirus late genes are 
characterized as those that are transcribed after viral DNA synthesis begins.  
The start of viral DNA synthesis is critical to late gene transcription, as a delay in 
DNA synthesis will result in a delay of late gene transcription.  The late genes 
are divided into two groups, late and very late.  Transcription of the late genes 
begins as early as 6 h p.i. and continues at high levels throughout infection.  
These genes typically encode the virus structural proteins.  The very late genes 
differ by the timing of transcription, a requirement of vlf-1, a late gene (71), and 
the abundance of protein produced.  The very late genes are expressed at very 
high levels from 18 h p.i. through the end of infection and encode polyhedrin, 
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p10 and granulin.  Both the late and very late genes, require a virus encoded 
RNA polymerase (α-amanatin resistant) and several other virus encoded genes 
(44, 72-74).  The late promoters have a conserved transcription initiation site, 
TAAG (34, 75).  These promoters lack a TATA box, and no other upstream 
regulatory sequences have been identified (75).  The very late genes, polyhedrin 
and p10, are transcribed from a consensus sequence, AATAAGATTTT (76).  It 
remains unclear what factors regulate the timing and expression levels between 
late and very late genes. 
Baculovirus: Structural composition of occlusions, virions, and viral 
envelopes.  The two forms of progeny virus, BV and ODV, have the same 
genome and a similar nucleocapsid structure.  Yet, the two forms differ in 
envelope morphology, source of viral envelopes, protein and lipid composition of 
the envelope, and the role in the infection process (77, 78).   
Viral occlusion structural composition.  Occlusion derived virus, ODV, is 
the form of the virus responsible for primary infection of the larval insect host.  
ODV is protected from the environment by encapsulation in viral occlusions 
called polyhedron for NPV, granules for GV.  Viral occlusions are soluble at pH 
9.5, which is similar to the pH of the insect midgut (6, 79).  Occlusions can range 
in size from 0.5 µm to 15 µm and contain from one to many virions (6). 
Polyhedron/granulin:  Viral occlusions are composed primarily of a single 
~29 kDa protein, polyhedron (NPV) or granulin (GV).  Polyhedron is a highly 
conserved baculovirus protein; BlastP (80) shows a minimum amino acid (a.a.) 
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sequence identity of 78% and similarity of 85% when comparing the AcMNPV 
polyhedron protein sequence to full length Lepidopteran baculovirus polyhedron 
protein sequences (data not shown).  Granulin is also very highly conserved 
having an a.a. similarity of 90% and identity of 81% among sequenced granulin 
proteins sequences (78).  Polyhedron and granulin have about 49% a.a. 
sequence identity (81, 82).  Polyhedron is expressed at very high levels during 
infection but is not essential in tissue culture.  Because of the high levels of 
expression, the polyhedron promoter is used worldwide to express foreign genes 
(16) with the baculovirus expression vector system (83). 
Polyhedra envelope/calyx:  Surrounding the viral occlusion is an electron 
dense region termed the polyhedra envelope (PE) or calyx.  Originally thought to 
be composed primarily of carbohydrates (84), the PE was determined to be 
sensitive to protease (85). The protein pp34 in AcMNPV (86), OpMNPV (87) and 
LdMNPV (88) was identified as the primary structural protein of the PE (85).  
Deletion of the pp34 gene resulted in electron dense structures surrounding 
polyhedra that were smaller and irregular in shape indicating the protein is 
required for proper formation of the PE (89-91).  The polyhedra envelope 
function is unknown.  Studies have shown that deletion of pp34 does not 
decrease the infectivity of the virus or offer protection against environmental 
factors (90, 92, 93). 
p10:  p10 is very highly expressed during infection.  Because the p10 is 
not essential for virus replication in cell culture, the promoter is also used for the 
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expression of foreign genes in the baculovirus expression vector system (94, 
95).  The 3’ un-translated region of p10 is important for efficient translation 
initiation and thus the expression levels of p10 or genes expressed from the p10 
promoter (96, 97).  Immunoelectron microscopy shows p10 forms intranuclear 
fibrillar structures that associate with pp34 in infected cell nuclei (82).  These 
fibrillar structures disappear in p10 deletions mutants (89).  Deletion 
mutagenesis has determined that both the N-terminal and  C-terminal portions of 
the p10 are required for the formation of the fibrillar structures (98).  The N-
terminal portion contains a conserved coiled-coil domain and is believed to have 
an aggregation function (99).  The C-terminal portion has been proposed to 
interact with cellular tubulin (100) and may also be associated with disintegration 
of the host cell nucleus (101). 
Nucleocapsid structural composition. The two forms of progeny 
baculovirus, BV and ODV, have a similar nucleocapsid structure and protein 
composition.  Nucleocapsids are rod shaped and measure 40-60 nm x 250-
300nm (up to 500nm) and are bacilliform in structure (6, 102).  Recently, a 
proteomics study of the composition of enveloped ODV was completed (39) and 
this study identified a number of viral proteins that had not been previously 
known to associate with ODV.  Only the most well described of these proteins 
will be discussed further.  A similar study of BV has yet to be completed.  Figure 
1 shows the BV and ODV structure and protein composition.  
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Figure 1.  Budded virus and occluded derived virus structure and protein composition.  
Adapted from Funk et al., (1997) (78). 
 
p6.9: A DNA binding protein of the nucleocapsid composed of 40% 
arginine and 30% threonine or serine (78).  This protein’s a.a. content is similar 
to protamine, a protein involved in the condensation and packaging of DNA in  
sperm nuclei of mammals, fish and avian species (103, 104). Evidence suggests 
that p6.9 is responsible for the efficient packaging of viral DNA into  
nucleocapsids (105, 106). 
vp39-Capsid: This protein is one of the most abundant proteins of the 
nucleocapsids (107).  Immunoelectron microscopy shows that vp39 is uniformly 
distributed throughout the nucleocapsid structure (108).   Comparison of the a.a. 
sequences of 23 vp39 proteins using Pfam (109) shows an average identity of 
42% among the protein sequences.   
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vlf-1:  A late protein of baculovirus, vlf-1 is produced  from 15-24 h p.i. 
(western blot analysis).  It is involved in the regulation of very late genes (71), 
and is a structural protein of the nucleocapsids.  Efforts to generate a null mutant 
are not successful indicating this protein is likely essential (110).  Computer 
assisted analysis of the a.a. sequence shows this protein is a member of the λ-
phage integrase family of proteins (71).  Experimental evidence suggests that 
integrase activity by vlf-1 is required to produce viable virus (110).  By altering 
the time and level of vlf-1 expression, the timing and abundance of polyhedrin 
expression can be altered.  This indicates that vlf-1 is a regulator of very late 
gene expression and may regulate the timing of occlusion assembly (111). 
vp1054:  This BV/ODV protein is expressed from multiple promoters from 
early to very late times through infection and was identified by marker rescue 
experiments using a temperature sensitive mutant that does not form 
nucleocapsids (112). 
FP25K:  Naturally occurring viral mutants that produce a “few polyhedra” 
phenotype (FP) were first observed by Hink and Vail, (113).  Several unique 
mutations in the viral genome including insertions, deletions and a.a. 
substitutions produce the FP phenotype.  Analysis of 9 FP viral isolates identify 
a gene that consistently contains mutations resulting in the FP phenotype (114, 
115) termed FP25K.  The function of FP25K is unknown, but the protein 
localizes in electron dense regions in the cytoplasm and the nucleus (116) and is 
a structural protein of BV/ODV nucleocapsids (117).  Infection with FP mutant 
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viruses result nucleocapsids that are associated with intranuclear membrane 
structures, but are not fully enveloped.  In the rare occasion that a nucleocapsid 
is fully enveloped, ultrastructural observations show the FP virus envelopes 
have a abnormal morphology as compared to wt ODV envelopes (116).  
Infection with a naturally occurring mutant virus, 480-1, which contain a N-
terminal a.a. deletion within FP25K, results in accumulation of the envelope 
protein, ODV-E66, in the cytoplasm as compared to wt infection where ODV-E66 
is detected in intranuclear microvesicles and ODV envelopes.  Infection with 
480-1 also results in a delay in the nuclear accumulation of another envelope 
protein, ODV-E25 (117).  Deletion of FP25K reduces the steady state protein 
levels of ODV-E66 five fold, however, there are no detectable changes in 
transcription levels of ODV-E66 when compared to wild type infection; 
suggesting that FP25K may be involved in regulating the translation of ODV-
E66.  Deletion of FP25K also results in E66 accumulation at the nuclear 
periphery, suggesting a role for FP25K in the trafficking of E66 to microvesicles 
and ODV envelopes (118).  Finally, in vitro and in vivo protein cross-linking 
studies identified FP25K is proximal to ODV-E66 in ER derived membranes, 
further supporting a hypothesis that FP25K may be involved in the trafficking of 
ODV-E66 (119). 
p78/83:  This BV/ODV protein is expressed late in infection (17, 120). 
Taking advantage of the gene’s genomic proximity to polyhedrin, and the fact 
that it is essential, Kitts and Possee (121) developed a selection system to 
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increase the yield of recombinant baculovirus with foreign genes inserted in the 
polyhedrin locus.  Immunoelectron microscopy revealed that p78/83 is localized 
to the basal end of the nucleocapsid, oriented away from the virogenic stroma 
(during encapsulation), intranuclear microvesicles (during envelopment) and the 
nuclear envelope (during cytoplasmic budding) (122).  Yeast two-hybrid 
screening and blue native gel electrophoresis identify this protein in putative 
complexes with BV/ODV-C42 and/or ODV-EC27 (123).  In addition to the two 
viral proteins, p78/83 has also been shown to bind actin.  This actin binding is 
suggested to be involved in actin polymerization, facilitating the transport of 
nucleocapids to the nucleus upon infection (124).  Additionally, p78/83 
associates with viral induced RNA polymerase, suggesting a role for p78/83 in 
the polymerase activity (125)  
BV/ODV-C42 (C42):  Expressed as a late gene product of orf 101 this 
protein is a structural component of BV/ODV nucleocapsids.  At 24 h p.i., C42 
localizes to the virogenic stroma, an intranuclear electron dense region 
associated with viral DNA replication.  By 72 h p.i. C42 is dispersed evenly 
throughout the nucleus.  Yeast two-hybrid and blue native gel electrophoresis 
identified p78/82 and/or EC27 in putative protein complexes with C42 (123). 
ODV-EC27 (EC27):  Both a capsid and envelope protein found only in 
ODV (126).  The sequence from a.a. 80-110 of EC27 has a 25-30% similarity to 
the cyclin box sequence of several cellular cyclins (human/Drosophila cyclin B, 
Human cyclin D1, D2).  Additionally, this protein co-immunoprecipitates with 
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cdc2 and/or cdk6 with kinase activity capable of phosphorylating histone H1 and 
retinoblastoma in vitro.  These results indicate that EC27 may function as a 
multi-functional virus encoded cyclin [cdc2-EC27 (B like cyclin), cdk6-EC27 (D-
like cyclin capable of binding PCNA)] (127). 
Other nucleocapsid proteins:  The proteins, p24 (128) and p87 (129) are 
structural components of nucleocapsids, although the function(s) of these two 
proteins are unknown.  An exhaustive proteomic analysis of the ODV viral form 
identify several viral proteins as structural components of the nucleocapsid that 
have not been previously reported (39).  The newly identified proteins are: DNA 
polymerase, lef3, hcf-1, helicase, IE1, lef1, p43, PNK/PNL, cg30, p33, alkaline 
exonuclease, and open reading frames Ac30, Ac66, Ac102, Ac109, Ac114, 
Ac132, Ac142.  The functions of many of these newly identified proteins have 
been determined or postulated, but is beyond the scope of this review. 
Tegument. The tegument is defined as the area between the viral 
envelope and the nucleocapsid in BV or ODV.  Fractionation studies indicate 
GP41 fractionates with nucleocapsids and viral envelopes and, as such, has 
been termed a tegument protein (130).  GP41 is a N-glycosylated protein of 
ODV (130).  GP41 is late gene transcribed from 12 to 36 h p.i. (131).  Data from 
a temperature sensitive mutant of GP41 show that BV is not produced at the 
non-permissive temperature suggesting a role for GP41 in BV maturation (132).   
Budded virus envelope composition.  The BV enters the cell by receptor 
mediated endocytosis (133).  During endocytosis, the acidic pH of the endocytic 
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vesicle lumen activates fusogenic protein(s) in the virion envelope, which results 
in fusion of the envelope with the endosome membrane.  This fusion releases 
the nucleocapsid in the cytoplasm.  Two fusogenic proteins have been identified 
in BV envelopes, GP64 and F-protein (134, 135).  At least three proteins reside 
in the envelope of both BV and ODV.  These proteins will be discussed with the 
details of the ODV envelope proteins. 
 GP64/GP67:  GP64 is expressed as both an early and late gene (66, 
136), and was the first protein identified as a fusion protein of BV envelopes 
(135).  This protein localizes to the plasma membrane (PM) of infected cells (66) 
and the envelopment of the nucleocapsids appear to originate by budding from 
the GP64 rich PM regions.  In BV, GP64 is a homotrimer localized in spike-like 
structures (peplomers) at one end of the virion (137).  Antibodies directed 
against GP64 can block the membrane fusion activity thus decreasing the 
infectivity of the virus (138).   Studies using a GP64 null mutant show that the 
protein is essential for cell to cell transmission of budded virus, although this null 
mutant virus does produce infectious occlusions (139).  GP64 is both 
glycosylated and palmitoylated, with palmitoylation functioning in membrane 
anchoring, protein mobility within membranes, or regulation of trafficking in the 
cell (140, 141).  Two domains within the protein are required for GP64 function.  
The fusion domain (a.a. 223-228) is required for pH activated membrane fusion 
of this protein (135, 138).  The oligomerization domain (a.a. 327-335) constitutes 
a leucine zipper required to form the mature GP64 homotrimer (142).  
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Additionally, GP64 is likely involved with the establishment of secondary “ pass 
through” infection by ODV derived virions (143). 
 Fusion protein/F-protein:  Sequence analyses of the known baculovirus 
genomes reveal that several baculoviruses lack GP64 (group II baculoviruses).  
Computer assisted analysis of the group II baculovirus, LdMNPV, identify a 
single protein, LD130, with a predicted transmembrane domain and signal 
sequence.  LD130 accumulates in the plasma membrane of infected cells and 
induces membrane fusion at pH 5.0. Therefore, LD130 is considered a 
fusogenic or F-protein of the group II BV (134).  A F-protein homolog has been 
identified in all of the group I and group II baculoviruses except NeleNPV (1), 
however for at least OpMNPV and AcMNPV (group I baculovirus), the F-protein 
homolog could not act as a pH-mediated fusion protein (144, 145).  Recently, F-
proteins from LdMNPV or SeMNPV (group II baculoviruses) were used to 
replace GP64 in AcMNPV.  The AcMNPV encoded F-protein homolog could not 
compensate for the GP64 deletion alone (145), however the F-protein from 
either group II virus can act as a functional replacement for GP64 in the GP64 
null mutant AcMNPV BV virions (146).  This data indicates that even though 
group I baculoviruses encode a F-protein homolog, it functions differently than 
the group II baculovirus f-protein.   
Occlusion derived virus envelope composition.  ODV nucleocapsids are 
assembled and enveloped in the nucleus.  The source of the envelope is unique 
as it does not appear to be derived directly from the nuclear envelope, but 
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instead the envelope is apparently derived from viral-induced intranuclear 
microvesicles (MV) that bud from the INM (147, 148).  Ultrastructural 
observations of membrane elements during Dipteran NPV envelopment 
suggests that the precursor membranes of viral envelopes are synthesized de 
novo during infection (149).   However, ultrastructural observations during 
Lepidoteran NPV infection and envelopment shows perturbations in the nuclear 
envelope that are induced during infection suggesting that microvesicles may be 
produced by budding from the inner nuclear membrane (150).  Additionally, 
when the ODV-envelope proteins, ODV-E66 (148) and ODV-E56 (151), are 
abundantly expressed (polyhedrin promoter) these proteins are detected in MV 
and viral envelopes as well as in the INM, ONM and ER.  These observations 
led to the hypothesis that the virus-induced MV originate from the INM and act 
as precursors of the ODV envelopes (151). 
ODV-E66 (E66):  This late baculovirus ODV envelope protein was 
identified by N-terminal sequencing of a SDS-PAGE band unique to purified 
ODV envelope samples.  E66 is transcribed from 12 to 72 h p.i.  This protein is 
expressed from 24 through 72 h p.i.  Western blot and/or immunoelectron 
microscopy detects E66 in ODV envelopes and viral-induced intranuclear MV 
(148).  Yeast two-hybrid direct cross assays identify the viral proteins FP25K, 
p39 and/or ODV-E25 may each interact with E66 independently (117).  When 
FP25K is deleted from the genome, E66 is detected mostly in clusters in the 
outer nuclear membrane, and is not detected in the microvesicles or ODV 
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envelopes.  This suggests that FP25K plays an important role in the trafficking of 
E66 during infection (118).   
The N-terminal 33 a.a. of E66 constitute a hydrophobic, non-cleaved, 
Type I signal anchor sequence.  This region of E66 is termed the sorting motif 
(SM) (119).  When the SM is fused to green fluorescent protein (GFP) or β-
galactosidase (β-gal), the fusion proteins localize to intranuclear microvesicles 
and ODV envelopes during infection.  Additionally, when the SM-fusion proteins 
are abundantly expressed (polyhedrin promoter), they localize in the inner 
nuclear membrane (INM) and outer nuclear membrane (ONM), and ER 
membranes in close association with the NE (152).  When the a.a. sequence of 
the SM is compared to the a.a. sequence of the known INM proteins, the 
chemical features of the SM are conserved.  In vivo and in vitro crosslinking 
studies show the viral proteins, FP25K and BV/ODV-E26, are proximal to E66 in 
the ER, suggesting these proteins may regulate the trafficking of SM prior to 
localization in the MV and viral envelopes (119).  A detailed discussion of the 
SM features is found in the specific aims section of this thesis.  A 
comprehensive study of the chemical features of the E66 SM, and the possible 
role(s) in sorting integral membrane proteins to the INM is the major goal of this 
study.   
 ODV-E25 (E25):  E25 is a late baculovirus protein.  It was identified in 
OpMNPV by screening λgt11 expression libraries using antibodies generated 
against ODV virions.  A monospecific antibody detects E25 as a doublet on 
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western blots, and detects the protein in ODV envelopes when used for 
immunoelectron microscopy (153).  Hong et. al. (152) determined that the E25  
N-terminal 24 a.a., which are chemically similar to the E66 SM, are also 
sufficient to direct a GFP fusion to intranuclear MV and ODV envelopes, as well 
as the INM, ONM and ER membranes in close association with the NE (152).  
While E25 trafficking to the nucleus is delayed in naturally occurring FP25K 
mutants (480-1) (117), the trafficking is apparently not affected in the FP25K 
deletion virus (118). 
 ODV-E56 (E56):  E56 is a baculovirus late protein, with the gene 
transcribed from 16 to 72 h p.i. and protein produced from 36 to 96 h p.i. (151, 
154). This protein was identified through screening λgt11 expression libraries 
from AcMNPV infected cells using antibodies generated against ODV or BV 
(151).  E56 is an ODV envelope protein (immuno-electron microscopy) that is 
also detected in virus-induced MV and the INM and ONM (151, 154).  By 
replacing the C-terminal 204 a.a. of E56 with β-gal, the fusion protein localizes to 
nucleocapsids of ODV, but not viral envelopes or microvesicles.  This data 
indicates that the C-terminus of the protein contains the sequence(s) required for 
membrane association and localization to ODV envelopes and microvesicles 
(155). 
 ODV-E18 (E18) and ODV-E35 (E35):  E18 is transcribed as a late gene 
(transcripts are detected from 16 h p.i. thru 72 h p.i.) and the protein is detected 
from 24 h p.i. thru 72 h p.i.  It was identified by N-terminal sequencing of an 18 
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kDa band from purified ODV envelopes, however the gene encodes a predicted 
9.5 kDa protein.  In vitro translation produces only a 9.5 kDa form, indicating that 
the protein is likely a dimer in infected cells (126).   
Translation of both E18 and EC27 (envelope and capsid protein of ODV, 
putative viral cyclin) is initiated from the same mRNA.  The E35 protein is 
proposed to be translated from this mRNA product as a result of ribosomal 
frame shifting at the 3’ end of the E18 coding sequence, which takes the E18 
stop codon out of frame, and places the EC27 coding sequence in frame (126).  
N-terminal sequencing shows that E35 has the same N-terminal sequence as 
E18.  Both the E18 and EC27 antisera detect E35 on western blots of purified 
viral envelopes, indicating E35 is likely a structural protein of the ODV envelope.  
Using E18 antisera, immuno-electron microscopy was used to determine that 
E18 and/or E35 is present in the viral-induced microvesicles and ODV 
envelopes (126). 
 p74:  p74 is an ODV envelope protein (156). The gene was identified as 
an open reading frame (orf) positioned 3’ to the p10 open reading frame.  
Deletions in the C-terminus of the p74 yields viral occlusions unable to infect 
larvae by feeding (157).  Deletion of full-length p74 has the same affect, 
however injection of virions purified from the mutant occlusions are infectious.  
These studies show that p74 is required for primary infection of the insect midgut 
(156-158).  This protein localizes in the intranuclear MV of infected cells, and in 
the membrane fraction of infected cell lysates.  A microscopy study showing the 
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effects of deletions within p74 demonstrate that the C-terminal 65 a.a. are 
required for membrane association and localization specific to the intranuclear 
MV (159).  p74 mediates binding of the virus to the gut epithelium of infected 
larvae suggesting that like BV, ODV requires specific receptor binding for viral 
adhesion and entry into the host cell (160).   
 ODV-EC43 (EC43):  A late protein, EC43 is a structural component of 
both the nucleocapsid and envelope of ODV.  EC43 is transcribed from 24 h p.i. 
through 96 h p.i. and the protein is detected from 36 h p.i. through 96 h p.i.  
Computer predictions do not identify a signal peptide or TM sequence encoded 
within the protein.  Fractionation studies show that while EC43 is present in both 
capsid and envelopes preparations, the majority of the protein is in the capsid 
fraction (161). 
 p91: The p91 protein is detected late in infection, and is present in both 
ODV and BV envelopes (39, 162).  It was identified by screening λgt11 
expression libraries using antibodies directed against ODV virions.  
Immunoelectron microscopy shows p91 is present in both the envelope and 
capsid of ODV, but extraction by NP40 detect the protein only in the capsid 
fraction.  These results suggests that p91 maybe a capsid associated protein 
and that if it is present in the envelope, it is also linked to the capsid in a manner 
that is resistant to detergent or reducing conditions (162). 
 BV/ODV-E26 (E26):  BV/ODV-E26 is another protein reported that is 
detected in the envelopes of both BV and ODV (163).  E26 is only found in the 
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group I baculoviruses and is likely an essential gene of these viruses (164).  This 
protein is expressed and detected beginning at 4 h p.i. and continuing 
throughout the infection process.  E26 is detected in foci of both the cytoplasm 
and nucleoplasm prior to 16 h p.i. (163, 164). The E26 detected in the nucleus 
co-localizes with IE1 in the nucleus through at least 20 h p.i. (164).  Additionally, 
at 24 h p.i., E26 is detected in intranuclear microvesicles and ODV envelopes 
(163).  Biochemical assays show that E26 binds nucleic acids (164).  Co-
immunoprecipitation experiments and/or yeast two-hybrid assays predict FP25K 
and/or cellular actin can interact with E26 (163).  In vitro and in vivo crosslinking 
studies show that E26 is proximal to the E66 SM in the ER suggesting a 
possible role in protein trafficking of ODV envelope proteins (119). 
Pif, “per os infectivity factor”:  Pif is a late protein that is expressed at 
relatively low levels (165).  The N-terminus of pif has a SM-like sequence with a 
similar chemical structure as the E66 SM (Braunagel, personal communication).  
The pif protein was identified by studies of a SeMNPV mutant virus that 
produces occlusion bodies not capable of infecting larvae by feeding (per os) 
(166).  Western blot analysis shows the protein fractionates as a ODV envelope 
protein (166).  A recent study (Braunagel, personal communication) shows that 
pif is also a BV envelope protein.   
Pif2:  Like Pif, this protein was identified as a protein responsible for loss 
of per os infectivity by a SeMNPV mutant virus with a deletion of orfs 29-35.  
Computer assisted analysis identifies a late gene promoter, suggesting pif2 is 
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likely a late gene (167).  Like pif, the N-terminus of pif2 has a SM-like sequence 
with chemical characteristics similar to the E66 SM (Braunagel, personal 
communication).  The presence of this SM-like sequence suggests pif2 is likely 
an envelope protein. 
Ac150: Ac150 is an envelope protein of both BV and ODV.  Deletion of 
Ac150 combined with a deletion in Ac145 results in virus that has a 39-fold 
decrease in per os infectivity.  Since deletions still result in the production of 
virus, Ac150 is considered to be non-essential (168). 
 Other ODV envelope proteins identified by a proteomic analysis of ODV:  
With the exception of a few of proteins (E26, pif, and Ac150) an exhaustive 
proteomics study of AcMNPV ODV proteins confirmed the identity of all the 
previously described envelope proteins of the ODV envelope.  Additionally, gp41 
and F-protein were both identified as structural proteins of the ODV envelope 
(39).  Previous reports identify gp41 as a tegument protein (130), and as such 
this protein would likely contaminate envelope preparations.  However, F-protein 
is the fusogenic protein of group II NPV and GV baculoviruses that was only 
found in BV prior to the proteomic study (134, 146).  The function of F-protein in 
the ODV envelope is unknown. 
Nuclear envelope: Structure and function.  The nuclear envelope (NE) is a 
specialized membrane system in eukaryotes that separates the nucleus from the 
cytoplasm and maintains the biochemical identities of the two compartments 
(169).  In addition, the NE is involved in “communication” between the cytoplasm 
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and nucleoplasm through the nuclear pores and also is involved in the regulation 
of DNA replication, gene expression and mitosis.  The NE is made up of two 
membrane bilayers, the ONM and the inner nuclear membrane INM.  These 
membranes are joined at the nuclear pore complexes 
 
Figure 2.  Structure of the nuclear envelope.  A.) Electron micrograph of the NE from rat liver 
nuclei.  The outer and inner membranes are clearly visible as are the junctions of these two 
membranes at the nuclear pores (arrows).  The inset image shows ribosomes attached to the 
ONM (170).  B.) Illustration showing the proteins of the nuclear envelope, and its general 
structure (170).   Abbreviations are listed in the abbreviations section of this thesis (pp. xiv-xiii).  
This figure is reprinted with the permission of the copyright holder, Nature Publishing Group. 
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 (NPC) via the nuclear pore membrane (NPM) (171).  Figure 2A illustrates this 
continuity.  The INM is lined with a network of proteins called the nuclear lamina 
that act as a structural framework for the nucleus and also may be involved in 
the regulation of chromatin structure and condensation and/or the localization of 
proteins to the INM (172).  A group of diseases termed the laminopathies are 
characterized by mutations in the lamina proteins and/or the lamina associated 
proteins (170, 173). 
Outer nuclear membrane.  The ONM is functionally and structurally 
continuous with the ER.  Ribosomes are even observed docked at the 
cytoplasmic face of the ONM (Fig. 2A) (170).  The ONM is connected to and 
continuous with the INM via the NPM.   
Nuclear pore complex, nuclear pore membrane.  The nuclear pore 
complex (NPC) separates the ONM and the INM and is anchored in the NPM by 
the integral membrane nucleoporin proteins of the pore complex (171).  The 
NPC acts as a gateway to control the exchange of macromolecules and 
macromolecular complexes between the nucleoplasm and the cytoplasm via 
signal-mediated transport (174).  NPCs are large protein complexes of 125 MDa 
in vertebrate cells (175) and ~66 MDa in yeast (176).  Despite the size 
differences, the yeast and vertebrate nuclear pores have the same general 
structure and likely use similar mechanisms for both soluble and membrane-
mediated protein transport. The protein composition of the yeast nuclear pore 
and the specific localization of these proteins within the pore were analyzed 
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using mass spectrometry and immunoelectron microscopy (176).  From these 
analyses, the yeast nuclear pore complex is predicted to consist of 29 
nucleoporins.  The vertebrate NPC is believed to consist of approximately 50 
nucleoporins (177).  The specific function(s) of each nucleoporin is unknown and 
currently under investigation.   
 
 
 
Figure 3.  Schematic of the structural organization of the nuclear pore complex.  This 
figure is reprinted with permission from the Journal of Biological Chemistry (178). 
 
NPCs (see Fig. 3, schematic) display an octagonal rotational symmetry.  
The core of the NPC is composed of the central transporter and the spoke/ring 
complex.  The central transporter forms the channel connecting the nucleoplasm 
and cytoplasm and interacts with nuclear import and export complexes as they  
traverse through the center of the NPC.  The transporter is embedded in the 
octagonally symmetric spoke/ring complex, which also anchors the NPC in the 
pore membrane.  The cytoplasmic and nucleoplasmic coaxial rings flank the 
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spoke ring complex, and these coxial rings anchor the cytoplasmic filaments and 
nuclear basket to the NPC, respectively (179).  The cytoplasmic coaxial ring is 
composed of three separate components, the star ring, the thin ring and internal 
filaments.  The star ring is the central structure of cytoplasmic ring.  Cytoplasmic 
filaments, which act as docking sites during signal mediated import and export of 
macromolecules (180), attach in eightfold symmetry to the star ring via the thin 
ring.  The star ring joins the spoke/ring complex to the NPC core by eight 
internal filaments, arranged in a hub and spoke conformation.  The 
nucleoplasmic coaxial ring is anchored to the nucleoplasmic side of the of the 
spoke-ring complex and like the rest of the pore, displays an eightfold symmetry.  
Filaments protrude from nucleoplasmic coaxial ring and join a smaller 
nucleoplasmic ring to form the nuclear basket (179, 181).  Current evidence 
suggests that the nuclear basket is involved in nuclear export of both protein and 
RNA (182, 183) as well as being involved in the termination of nuclear protein 
import (184).  
Transport of macromolecules through the NPC.  There are three methods 
for transporting macromolecules through the NPC: free diffusion, signal-
mediated transfer (import and export), and integral membrane protein trafficking. 
Free diffusion:  The NPC appears to allow free diffusion of some 
macromolecules.  Microinjection of labeled dextrans of various sizes show that 
the rate of diffusion is controlled by the molecule’s size; larger molecules diffuse 
at a slower rate than smaller molecules.  These experiments also show that free 
28 
diffusion is limited to macromolecules smaller than 50 kDa.  Free diffusion is 
believed to occur through the 8 peripheral channels located around the nuclear 
pore between the spokes of the spoke-ring complex, and not through the central 
transporter (185, 186).  These peripheral channels are shown to be 10 nm in 
diameter (175), which concurs with the size of the molecules that freely diffuse.  
However, many proteins that are small enough to diffuse, such as histones, still 
use signal-mediated transfer (187). 
Signal-mediated transfer:  Molecules that are too large to diffuse through 
the NPC, and many small macromolecules, use signal-mediated transfer to 
translocate across the nuclear pore.  Import and export each utilize unique 
signals, NLS (nuclear localization signal) and NES (nuclear export signal), 
respectively (180).   The “classical NLS” identified in SV40 large T-antigen 
contains a sequence of basic a.a., KRKK or similar (188).  In addition, a bipartite 
NLS, composed of two basic sequences of a.a. separated by a 10 a.a. spacer 
was identified in nucleoplasmin (189).  The NES contains a leucine rich a.a. 
sequence (190, 191).   
Nuclear import is accomplished in three steps: docking, translocation and 
dissociation.  In the docking step, NLS containing cargo binds a soluble import 
carrier protein, importin β or another karyopherin, in the cytoplasm.  The NLS 
cargo may bind the carrier protein either directly (importin β or transportin), or 
indirectly (importin β) via adaptor proteins such as importin α.  These adaptor 
proteins may regulate nuclear import as each adaptor can bind a particular NLS 
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with higher or lower affinities compared to other adaptors [reviewed in Macara, 
(192)].  Once the import complex is assembled, it is targeted to the nuclear pore, 
facilitated through interactions with the cytoplasmic fibers of the pore complex. 
Translocation results in the movement of the import complex across the nuclear 
pore through the central transporter.  This process requires the small G-protein 
Ran.  The majority of Ran is found in the nucleus, in the form of Ran-GTP, 
whereas the cytoplasmic pool of Ran is in the form of Ran-GDP.  The RanGTP-
RanGDP gradient facilitates the translocation of substrates across the pore, as 
import complexes assemble in the presence of cytoplasmic Ran-GDP, and 
disassemble in the presence of the nucleoplasmic Ran-GTP.  During the 
process of translocation, import complexes bind Ran-GDP via the importin, and 
through (putative) interactions with the FG repeats of nucleoporins (193), the 
entire complex translocates through the pore.  Once the complex has reached 
the nucleoplasmic side of the pore, the import complex dissociates. Ran-GDP is 
then converted to Ran-GTP by RCC1 (Ran GDP-GTP exchange factor) and 
Ran-GTP and the importins are recycled to the cytoplasm.  When Ran-GTP is in 
the cytoplasm, it is hydrolyzed to Ran-GDP.   
Proteins and substrates (RNA, RNA/protein complexes) are exported 
from the nucleus following a similar pattern.  The NES-containing molecule binds 
an exportin (i.e. Crm1) in the presence of Ran-GTP, and the entire complex 
translocates to the cytoplasm where it dissociates in combination with the 
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hydrolysis of Ran-GTP to Ran-GDP (191) [Reviewed in Kaffman and O’Shea, 
(194) and Macara, (192)]. 
Inner Nuclear Membrane (INM).  The INM is continuous with the ONM via 
the NPM.  The INM has a unique protein complement as compared to the NPM 
or ONM.  Proteins of the INM are involved in regulation of DNA replication, 
mitosis, chromatin, apoptosis and nuclear structure [reviewed in Worman and 
Courvalin, (195)].   
Sorting, localization and accumulation of membrane proteins to the INM.  
Accumulation of membrane proteins in the INM is not as well characterized as 
the accumulation of soluble proteins to the nucleus.  The accepted model for 
localization of proteins to the INM is “diffusion:retention” (196, 197).  This model 
predicts: following insertion, INM proteins randomly diffuse within the continuous 
membranes of the ER and NE and once in the INM, are immobilized and 
retained through binding interactions with either immobilized nucleoplasmic 
components, and/or other resident INM proteins (195-198).  Therefore, 
localization to the INM can be regulated by both the limits of diffusion through 
the NPC and well as the ability of a protein to become immobilized via binding 
interactions at the INM.   
The INM and ONM are continuous membranes connected through the 
peripheral channels of the NPC via the nuclear pore membrane.  According to 
diffusion:retention, proteins which diffuse from the ONM to the INM must have 
cytoplasmic/nucleoplasmic domains that are small enough to pass through the 
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10nm peripheral channels.  Thus proteins with domains larger than 45-70 kDa 
should not be able to diffuse from the ONM to the INM, and are thus excluded.  
Most of the INM proteins studied to date have domains smaller than 45-70 kDa 
(199-201) supporting the idea that diffusion may be sufficient for protein 
trafficking to the INM.  However, recently one group of INM proteins have been 
identified that contain cytoplasmic/nucleoplasmic domains up to 1mDa in size 
(202-204), suggesting that in addition to diffusion, there may be additional steps 
in trafficking proteins to the INM. 
Once a membrane protein is located in the INM, diffusion:retention 
predicts that only those proteins that are immobilized via binding nuclear ligands 
or other immobilized INM proteins will be retained in the INM.  In fact, the model 
predicts that integral membrane proteins destined for other cellular locales may 
be localized transiently in the INM.  However, because these proteins lack a 
binding domain for immobilized nucleoplasmic components, they would continue 
to diffuse within the continuous membrane systems of the ER and NE, and 
therefore not concentrate in the INM to detectable levels.  Ligand binding assays 
(201, 205-212) and FRAP experiments (198-201) show that not only do several 
INM proteins bind to nuclear ligands, but they are immobile in the INM.  While a 
considerable amount of data suggests that binding immobilized nuclear ligands 
is required for accumulation in the INM, there is a small pool of data that 
suggests that binding these nuclear components is not necessary (196, 198).  
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One major objective of this study is to determine if immobilization in the INM is 
required for accumulation.   
Protein composition of the inner nuclear membrane (Fig. 2B, pg. 24). 
Lamin B Receptor (LBR).  LBR is an integral membrane protein, p58, 
which localizes in the INM (205).  Sequence analysis of the LBR cDNA shows 
the calculated molecular mass of the protein to be 73,375 kDa (621 a.a.) 
although the SDS-PAGE Mr is 58 kDa .  The protein contains a 208 a.a. N-
terminal region followed by 8 transmembrane (TM) sequences.  The region of 
the LBR from 208-621 has a high homology with human, plant and yeast sterol 
reductase (213).  LBR rescues sterol reductase activity in both yeast (214) and 
Neurospora crassa (215) that are both deficient in sterol reductase activity.  It is 
currently unknown if LBR acts as a sterol reductase in mammalian cells (216).  
The N-terminal 200 a.a. region of LBR contains three DNA binding motifs and 
two conserved protein kinase phosphorylation sites.  In vitro and in vivo, the 
protein is phosphorylated, regulating lamin B binding.  Binding of the N-terminal 
segment of LBR to lamin B binding suggests the N-terminus is oriented toward 
the nucleoplasm (217).   
When the N-terminal 200 a.a. region of LBR is fused to the N-terminus of 
type II integral membrane proteins, the chimeric fusion proteins sort to the INM.  
When this region of LBR is fused to soluble cytoplasmic proteins, the fusion 
proteins are sorted to the nucleoplasm (197, 218). When the N-terminal 238 a.a. 
of LBR (N-terminal binding domain and first TM sequence) are fused to GFP and 
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expressed in mammalian (199) or plant (219) cells, the fusion protein localizes to 
the INM.  These data suggest that the amino-terminal 200 a.a. are necessary for 
INM protein localization.  However, when the N-terminal 192 a.a. of LBR is 
replaced with β-gal, the resulting fusion protein accumulates in the INM as well 
as a distinct set of cytoplasmic membranes.  Additionally, deletion of the first 190 
a.a. of LBR results in protein accumulation in the INM.  Finally, when the TM 
sequences 2-8 are deleted, the truncated LBR also accumulates in the INM 
(196).  Thus, these data suggest that the first TM sequence of LBR is sufficient 
for accumulation of proteins to the INM.  The first TM sequence of LBR is 
chemically similar to the ODV-E66 SM.  One goal of this study is to determine if 
the viral SM or the SM-like sequence of LBR is sufficient for accumulation of 
protein in the INM.  
FRAP (fluorescence recovery after photo-bleaching) studies show that 
when the N-terminal 238 a.a. of LBR are fused to GFP, the protein is immobile in 
the INM, but remains mobile in the ER (199).  LBR binds lamin B (205, 206), 
DNA (206), chromatin (207) and HP1, a chromatin binding protein (208) via the 
nucleoplasmic, 200 a.a. N-terminal domain.  Binding to one or more of these 
nucleoplasmic components is the accepted mechanism for sorting and 
immobilization (retention) of LBR in the INM.  This binding data along with the 
FRAP data support the fundamental basis of the hypothesized diffusion:retention 
model of INM protein sorting and localization.   
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Lamin Associated Polypeptides (LAP).  The LAP proteins consist of two 
types, LAP1 and LAP2.  Each type has several variants that differ in 
sequence(s), function(s), and/or localization(s).  LAP1 proteins are Type II 
integral membrane proteins consisting of three variants: LAP1A, 1B and 1C 
(220).  High stringency hybridization studies indicate that each isotype of LAP1 
is a splice variant of the same gene (221, 222).  All three LAP1 forms interact 
with lamin A, mitotic chromosomes (209), lamin B and a protein kinase (220). 
These protein interactions are likely significant in maintaining nuclear structure 
and organization.  Localization studies of LAP1B using deletion mutants fused to 
GFP show that the LAP1B TM sequence is required for localization in the 
nuclear envelope and ER.  Together, the TM sequence and C-terminal segment 
of the nucleoplasmic domain function as the sorting and localization 
determinants for LAP1B (223).    
The LAP2 protein variants are mostly Type II integral membrane proteins, 
and exist in six different forms, LAP2 α, β, ε, δ, γ, and ξ.  LAP2β binds lamin B 
and the chromatin binding protein BAF (barrier to auto-integration factor) and is 
believed to be responsible for in nuclear reformation and organization at the end 
of mitosis (224).  LAP2β has a large hydrophilic nucleoplasmic region, followed 
by a C-terminal, 24 a.a. TM sequence, which acts to anchor the protein in the 
membrane.  When the lamin binding domain of the LAP2 N-terminus (a.a. 298-
373) is fused to a Type II membrane protein (chicken hepatic lectin), the 
resulting fusion protein sorts and localizes to the NE (225).  LAP2α is a soluble 
35 
form of the LAP2 protein family, and as such lacks the C-terminal TM sequence 
of LAP 2β.  It localizes uniformly in the nucleoplasm and interacts with lamin A, 
lamin B and chromatin and is believed to be important for nuclear assembly and 
structural organization (226).  LAP2 isoforms have a conserved 40 a.a. 
sequence in the N-terminal region of the proteins termed the LEM domain.  The 
LEM domain is found in at least two other INM proteins, emerin and MANI (227). 
This domain interacts with BAF (224).   
Emerin. Mutations in emerin are responsible for X-linked autosomal 
dominant Emery-Dreifuss muscular dystrophy (EDMD).  Additionally, studies in 
C. elegans suggests that emerin may be involved in cell division (228).  Emerin 
is a Type II integral membrane protein of 254 a.a., and contains a single TM 
sequence, 11 residues from the C-terminus, that anchors emerin in the INM.  
The N-terminal region (a.a. 1-188) of emerin interacts with the lamina (210).  
When the N-terminal 219 a.a. of emerin are fused to GFP, the resulting fusion 
protein localizes uniformly in the nucleus, but not in the INM (229).  When this 
region is fused to the type II integral membrane protein, chicken hepatic lectin, 
the fusion sorts and localizes to the INM (200).  When the C-terminal region (a.a. 
197-254) of emerin (includes the TM sequence) is fused to GFP, the fusion 
localizes in the ER (200).  These results suggest that the TM sequence of 
emerin is not sufficient to sort the protein to the INM, but that the N-terminal 219 
a.a. of emerin contains the sorting determinants (200, 229).  The N-terminal 219 
a.a. of emerin also contains the conserved LEM domain as discussed for LAP2 
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(201).  In addition, the N-terminal 219 a.a. of emerin binds A type lamins (211, 
212, 230), and FRAP data shows a significantly slower mobility in the INM than 
the ER (200).  These data suggest that sorting and retention of emerin in the 
INM is consistent with the diffusion:retention model.     
MAN I.  The MAN antigens were identified using auto-antibodies from an 
individual with collagen vascular disease.  One of the proteins identified in this 
screen, MAN I, localized to the INM (201).  MAN I is a 82.3 kDa protein, with a  
N-terminal region of 476 a.a. followed by two putative TM sequences and a 252 
a.a. C-terminal tail.  The N-terminal domain contains the conserved 40 a.a. LEM 
domain (201).  A fusion of the first 538 a.a. of MAN I (N-terminal region plus the 
first TM sequence) to GFP is sufficient to sort and localize GFP to the INM.  
Additionally, when the N-terminal domain of MAN I (without the first TM 
sequence) is fused to chicken hepatic lectin, this fusion sorts and localizes in the 
INM.  These results indicate that the N-terminal region of MAN I is necessary to 
direct membrane proteins to the INM (231).  Localization studies using the only 
TM sequence of MAN I have yet to be reported.  Studies in C. elegans suggest 
that MAN I is likely involved in cell division (228). 
Nurim.  Nurim was identified by screening a GFP fusion library for yeast 
proteins that localized to the NE.  Nurim contains five putative transmembrane 
sequences, however immunoprobing and protease protection assays show that 
Nurim spans the membrane six times (232).  However, Nurim lacks the large 
hydrophilic domain at the N-terminus that is present in the other known INM 
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proteins and has been shown to bind immobilized nuclear ligands.  Despite the 
apparent lack of a binding sequence, FRAP data shows that Nurim is 
immobilized in the INM.  This immobilization is predicted to occur by binding with 
other immobilized resident integral membrane proteins (198).  However, 
biochemical fractionation studies using conditions which extracted lamins A/C 
did not result in a release of Nurim from the insoluble (membrane) fraction (232).  
Mutational analysis shows that several regions of Nurim appear to be important 
for localization to the INM.  These include the second and third TM sequences 
as well as regions within the loops connecting the TM sequences of the protein.   
While the function of Nurim is currently unknown, sequence similarities suggest 
Nurim may have a isoprenylcysteine carboxymethyltransferase enzymatic 
function (232). 
Nesprins.  Nesprin (204), Myne I (203), and Syne I (202) are all members 
of an emerging class of INM proteins termed the Nesprins.  This family of 
proteins is characterized by having series of spectrin repeats up to one MDa in 
size resulting in proteins with very large nucleoplasmic regions (204, 233).  
Other known cellular proteins with spectrin repeats function in both structural 
and signaling roles at the plasma membrane (234).  Thus it has been proposed 
that nesprins may have structural and/or signaling roles in the nucleus.  
Nesprins co-localize with LAP1, emerin and lamin at the NE (204) and contains 
a LEM-like domain found in these proteins.  The presence of the LEM domain 
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suggests that the nesprins may bind lamin(s) A or C (203), and therefore could 
potentially be associated with one or more of the laminopathies (233). 
 Other integral membrane proteins of the INM.  Several other integral 
membrane proteins of the INM have been identified but not studied in detail.  
The ring finger binding protein is a type IV ATPase that has nine TM sequences, 
the most of any INM protein.  It contains a conserved ring finger binding motif 
common in several transcription factors, suggesting a role in transcriptional 
regulation (235).  Luma is a 45 kDa INM protein identified in a proteomic 
analysis of rat liver nuclei that likely interacts with the nuclear lamina (236), 
however little else is known.  In the same screen, UNC 84 was identified.  In C. 
elegans, UNC 84 is involved in nuclear migration during cell division (237).  UNC 
84 requires lamin for correct localization to the INM (238).  It binds to, and is 
required for localization of UNC 83, another protein involved in nuclear migration 
during cell division, to the INM (239).  UNCL contains five TM sequences and 
binds poly G RNA.  This protein contains a LEM-like domain, however binding to 
BAF and/or lamin has not been tested (240).  While characterization of these 
proteins is in the early stages, their identification illustrates the wide range of 
possible functions associated with INM proteins, many of which are yet to be 
discovered. 
Peripheral membrane proteins of the INM.  Two proteins have been 
identified in Drosophila as peripheral membrane proteins (241, 242) of the NE, 
Otefin (243) and YA (young arrest)(244).  YA is only expressed in ovaries and 
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early embryos (244), and interacts with chromatin (245) and lamin (242).  These 
interactions are hypothesized to contribute to nuclear structure and organization 
by mediating the association of chromosomes with the nuclear lamina (241).  
Otefin is a 45 kDa protein (407 a.a.) that contains a 390 a.a. nucleoplasmic 
domain followed by a C-terminal 17 a.a. hydrophobic tail, which is required for 
localization of the protein to the NE.  Amino acids 173-372 are also required for 
localization in the NE and a.a. 35-172 further stabilize the interaction between 
otefin and the NE (241).  Otefin interacts with the Drosophila lamina which is 
suggested as the mechanism used to sort otefin to the NE and/or lamina (242).  
Other viral proteins that sort and localize to the INM.  Prior to release from 
the PM, herpes viruses acquire a viral envelope by budding through specific 
domains in the INM remodeled by the virus.  This nuclear budding process 
suggests that Herpes envelope proteins are sorted to the NE during infection.  
Envelope protein gB1 (904 a.a.) localizes to the NE of HSV-1 infected cells.  The 
gB1 protein is not specifically targeted to the modified patches where HSV buds, 
but instead distributes evenly throughout the INM (246).  The 21 a.a. TM 
sequence (774-795) localizes chimeric proteins to the INM and the ER (247).  
Epstein Barr Virus gp350/220, another herpes virus envelope protein, also 
localizes in the INM, but unlike HSV gB, sorts specifically to regions of the INM 
where virus budding occurs.  However, the sequence of gp350/220 that 
specifies sorting and localization to the INM budding patches is yet to identified 
(248).  Adenovirus 2 AD2-11.6 protein is an 11.6 kDa glycoprotein protein of 
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unknown function.  This protein localizes to the NE of infected cells, has a single 
21 a.a. hydrophobic sequence, and is predicted to be a Type I membrane 
protein (249).   
Other proteins of the NE.  Using multidimensional protein identification 
technology and “subtractive proteomics”, 67 uncharacterized integral membrane 
proteins of the nucleus were recently identified.  Of these newly identified 
proteins, 23 map to chromosomal regions that are linked to several dystrophies.  
Microscopy shows that eight of these proteins localize to the NE.  Therefore, the 
authors predict the remaining 59 uncharacterized proteins also localize to the 
NE.  This study suggests that only a small portion of the total proteins of the INM 
have been characterized (250). 
Nuclear lamina.  The nuclear lamina acts as a structural framework of the 
nucleus and is directly juxtaposed to the INM on the nucleoplasmic side of the 
membrane.  The lamina is involved in cell cycle regulation, chromatin 
organization, DNA replication, cell differentiation, and apoptosis (172).  The 
primary components of the lamina are two types of intermediate filament 
proteins, type A and type B lamins (251).  Like all intermediate filament proteins, 
the lamins have variable N-terminal and C-terminal domains, but contain a 
conserved central, coiled-coil, rod domain.  This rod domain mediates the 
formation of head to tail lamin dimers (252, 253).  Lamins are unique when 
compared to other intermediate filament proteins because the C-terminus 
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contains both a nuclear localization signal (188) and a CaaX motif that acts as a 
site for prenylation (254).   
 The B-type lamins are expressed in virtually all somatic cells (169) and 
three different forms are produced from two genes.  Lamin B1 is encoded by the 
LMNB1, lamin B2 is encoded by the LMNB2 gene (255), and lamin B3 is a splice 
variant of LMNB2 (256).  Lamin B1 and B2 are two minor forms of the lamin B 
family and associate with membranes by isoprenyaltion (254). The major form of 
B-type lamin is soluble lamin B3.  Depletion of lamin B3 results in the loss of DNA 
replication in vivo, however addition of B3 to depleted extracts will rescue DNA 
replication (257).  
There are two primary forms of A-type lamins, lamin A and C.  The LMNA 
gene encodes both the A and C forms.  The amino terminal 566 a.a. of lamins A 
(646 a.a.) and C (572 a.a.) are identical, however alternative RNA splicing, 
yields two lamins with unique C-termini (258).  The lamin A, 98 a.a., C-terminal 
tail contains a CaaX sequence which is isoprenylated (254).  Lamin A is 
produced initially as a pre-lamin A before it is endoproteolitically cleaved, 
removing the last 18 a.a. including the farnesyl group (259).  Lamin C has a 6 
a.a. C-terminal tail which is not isoprenylated (254).  The A-type lamins are 
expressed in most somatic cells, however they are absent in undifferentiated 
cells of early embryos, some neuron cells and epithelial cells, and certain types 
of cancer cells (173).  While deletion of these proteins does not affect cell growth 
in vitro, at the organismal level the effects result in several laminopathies. 
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The only insect lamin system characterized is from Drosophila.  Two 
lamins, Lamin Dm0 (260) and Lamin C (261), have been identified.  The two 
lamins have a 46% sequence identity with each other, but have less than a 30% 
sequence homology with lamins from other species: Lamin B (Xenopus) and 
Lamin C (mammalian).  Despite the low sequence homologies, Lamin Dm0 is 
considered an analog to the B-type lamins, while Lamin C is an analog of the A-
type lamins (262). 
Diseases related to the nuclear envelope.  The laminopathies (table 2) 
are a group of inheritable diseases that are characterized by defects in proteins 
of the nuclear lamina or lamina associated proteins (170) and are the most 
characterized group of diseases associated with the NE.  The laminopathies are 
part of three different classes of inherited disorders: muscular dystrophies,  
 
Table 2 – Inherited disorders related to the nuclear envelope 
Disease Type Disorder Gene Mutation 
 
Muscular Dystrophy   
 X-Linked Emery-Dreifuss Muscular Dystrophy Emerin (263) 
 Autosomal Recessive Emery-Dreifuss Muscular 
Dystrophy 
LMNA (264) 
 Dilated Cardiomyopathy LMNA (265) 
 Limb Girdle Muscular Dystrophy LMNA (266) 
 
Lipodystrophy   
 Dunnigan Type Familial Partial Lipodystrophy LMNA (267) 
 Mandibuloacral dysplasia LMNA (268) 
 
Neuropathy   
 Charcot-Marie Tooth Disorder type 2B1 LMNA (269) 
   
References for each disease are listed next to the gene mutated.  
 
43 
partial lipodystrophy, and neuropathy.  Most of these diseases have been 
mapped to defects within the A-type lamins, however at least one of the  
laminopathies is associated with mutations in the lamin-associated INM protein, 
Emerin.  Two forms of Emery Dreifuss muscular dystrophies have been 
identified as laminopathies, X-linked autosomal dominant EDMD (Emery-
Dreifuss muscular dystrophy), and autosomal recessive EDMD.  Autosomal 
dominant EDMD has been mapped to mutations in Emerin (263).  To date, 
over 50 different pathogenic mutations have been described in Emerin.  Most of 
these mutations result in truncated products which are not expressed, however 
some of these mutations yield Emerin that no longer localizes to the INM (230).  
Autosomal recessive EDMD, and the other laminopathies previously mentioned 
have been linked to mutations in the Type A lamin gene, LMNA.  These 
mutations yield proteins that are not expressed or are assembly defective.  
Mutations within the lamins are also characterized by mislocalization of emerin 
to the ER as well as a diminished or absent heterochromatin layer in the nucleus 
(270).  In most cases, alterations in the integrity of the NE or the underlying 
structure of the lamina is believed to be the cause of the laminopathies, 
however, defects in nuclear positioning, or gene expression may also affect 
disease progression (170). 
Membrane proteins: Integration, orientation and sorting.  This study focuses 
on the sorting and localization of integral membrane proteins to the INM or ODV 
envelopes.  In general, biochemical fractionation techniques are used classify 
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membrane proteins as either peripheral or integral membrane proteins.  
Peripheral membrane proteins can be released from the membranes using 
gentle extraction conditions that leave the lipid bilayer intact (high ionic strength, 
extreme pH changes).  Peripheral membrane proteins associate with 
membranes either through ionic interactions with integral membrane proteins 
and/or phospholipids, amphipathic helices and/or covalent modification of a 
protein with fatty acids.  While proteins with fatty acid modifications are generally 
considered peripheral membrane proteins, during detergent fractionation they 
may fractionate as with either the detergent or aqueous phase, depending on 
the acyl modification and/or other interaction with the lipid bilayer.  While there 
are a few examples of INM and ODV envelope proteins that are likely peripheral 
membrane proteins [eg. Otefin (242), Lamin B (254), ODV-E26 (163)], most are 
integral membrane proteins [eg. LBR (217), ODV-E66 (148)].  Integral 
membrane proteins can associate with membranes by two methods: membrane 
spanning β sheet structures [commonly in the form of a β barrel; eg. Omp A, 
(271)] or membrane spanning α helices [eg. bacteriorhodopsin, (272, 273)].   
Release of integral membrane proteins from the membrane requires extraction 
conditions that disrupt the lipid bilayer (detergents) and/or denature the proteins 
(urea, SDS) (274).   
Membrane proteins may be integrated into membranes either co- or post-
translationally.  Most membrane proteins of the eukaryotic cell are inserted into 
the ER membrane co-translationally.  However, proteins that are anchored by C-
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terminal TM sequences [reviewed in Borgese et al. (275)], lipid modifications 
and/or amphipathic helices integrate into the membrane post-translationally.   
Co-translational integration of membrane proteins into the ER is mediated 
via a protein conducting channel called the translocon [reviewed in Johnson and 
van Waes, (276) and Alder and Johnson, (277)].  The translocon is a 
multifunctional heterotrimeric complex consisting of Sec61 α,β,γ and forms a 
gated, aqueous pore in the ER bilayer.  Other proteins can be associate with the 
translocon including: TRAM (translocating chain-associating membrane protein) 
(278), BiP and signal recognition particle (SRP).   
Membrane proteins are translated by cytosolic ribosomes.  As an integral 
membrane protein TM sequence (signal sequence) emerges from the ribosomal 
tunnel, the nascent chain and ribosome are bound by the SRP and translation is 
slowed or paused.  The SRP/ribosome/nascent chain complex is targeted to the 
translocon where SRP binds its receptor via a GTP dependent interaction.  
Following ribosome docking, SRP is released and translation resumes.  While in 
the translocon, the TM sequence is oriented with the N-terminus either toward 
the lumen or the cytoplasm.  The process of how a TM sequence adopts a 
particular orientation is not well understood, although experimental evidence has 
identified several features of the protein sequence that may regulate membrane 
protein orientation (discussed further on page 46).  TM sequence integration into 
the bilayer occurs either co-translationally or following translation termination 
and ribosome release.  Experimental evidence suggests that the timing of 
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integration may be dependent on whether the TM sequence acts as a signal 
sequence or a signal anchor.  Following release from the translocon, the 
membrane protein may be modified (signal sequence cleavage, etc.) before 
being sorted to the final destination in the cell.   
Integral membrane proteins may be initially targeted to membranes by 
either a cleaved signal sequence or a signal anchor sequence.  Regardless of 
the method of targeting, the general consensus in the literature classifies mature 
single spanning membrane proteins as either Type I (eg. ODV-E66) or Type II 
(eg. emerin) dependent on the orientation of the mature protein within the 
membrane (Fig. 4).  Polytopic membrane proteins (eg. LBR) can be further 
classified, but the literature presents no accepted consensus for classification of 
these proteins.   
The orientation of the TM sequence of a membrane protein determines 
what part of the protein is exposed to the cytoplasm or organelle lumen.  The 
final orientation of the protein in the membrane may determine what post- 
translational modifications can be made to the protein or what the protein can 
interact with or access.  Several factors are involved in determining the 
orientation that a particular membrane protein may assume including: charges 
flanking the TM sequence, the folding of the N-terminal domain, and/or the 
hydrophobicity of the TM sequence (279). 
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Figure 4.  Diagram of the types of single spanning membrane proteins (280).  
 
Statistical analysis of bacterial membrane proteins established the 
“positive inside rule.”  For bacterial membrane proteins, positive charges are 
more likely to be oriented on the cytoplasmic loops (281) of the proteins.  
Studies of eukaryotic proteins show similar results; the sequence flanking the 
TM that has a larger net positive charge is oriented on the cytoplasmic side of 
the membrane (282). 
Proteins with internal signal anchor sequences may have the N-terminal 
region exposed in the cytoplasm prior to translation of the TM sequence.  Thus, 
the N-terminal region can fold and assume a secondary structure prior to the 
SRP-mediated targeting of the nascent chain to the translocon (283).  This 
folding may inhibit the translocation of the N-termini of these proteins, resulting 
in the these proteins adopting a Type II orientation [reviewed in Goder and 
Spiess, (279)].  In fact, experimental evidence shows that truncations of the N-
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terminal domain of a Type II membrane protein can result in the protein adopting 
a Type I orientation (284).   
Hydrophobicity and length of the TM sequence within a membrane 
protein also affects the orientation of the TM sequence. Increasing the length of 
the TM sequence with hydrophobic a.a., can change the orientation of a Type II 
membrane protein to the Type I orientation (285).  Evidence suggests that as the 
overall hydrophobicity of a TM sequence increases, the greater the chance that 
the TM sequence will adopt a Type I orientation (286).  Finally, the gradient of 
hydrophobicity along a TM sequence may also have an effect on the orientation.  
The more hydrophobic end of the TM sequence is oriented on the lumenal side 
of the membrane (287).   
Sorting can be mediated by a.a. sequences encoded within the 
membrane protein [reviewed in van Vliet et al., (288) and Emanuelsson and von 
Heijne (289)], post translational modifications [reviewed in Chatterjee and Major 
(290)], oligomeric state [reviewed in Martin and Evans (291)], and/or TM 
sequence characteristics [reviewed in van Vliet et al., (288); Killian (292)]. 
Targeting signals encoded within a membrane protein can regulate sorting to 
specific organelles/membranes: ER [di-lysine motifs: Type I protein retention and 
retrieval sequence (293, 294), N-terminal +2 to +5 di-arginine motifs:Type II 
protein retrieval and retention sequence (295)] or the plasma membrane [YXXΦ  
motif (where Φ is any aromatic amino acid)(296-298) or di-leucine motif: 
basolateral sorting in polarized cells (299)].  Membrane proteins may also be 
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sorted as a result of post-translational modification: glycosylphosphatidylinositol 
anchors [apical PM sorting via lipid raft association (290, 300)] or N- or O-linked 
glycans [apical PM sorting (301)].  For some membrane-bound golgi enzymes, 
oligomerization is also suggested as a mechanism of retaining these enzymes in 
the correct compartment of the golgi (302, 303).      
The TM sequence of a membrane protein can contain sorting 
determinants.  TM sequence length, hydrophobicity, and the flanking sequences 
can all influence the localization of membrane proteins in the cell.  Lipid bilayer 
thickness and cholesterol concentrations increase in membranes from the ER to 
the PM (304, 305).  Matching this increase in membrane thickness and/or 
increase in cholesterol content, TM sequences of PM proteins are an average of 
5 a.a. longer than TM sequences of golgi proteins.  Increasing the length of a 
golgi membrane protein TM sequence can result in protein sorting to the PM 
(306-308).  Experiments with an ER tail anchored protein showed that increasing 
the length of the TM sequence from 17 a.a. to 21 or 26 a.a. results in sorting of 
the protein to the golgi or PM, respectively (309).  Studies conducted in plants 
also show that lengthening or shortentening the length of a TM sequence can 
modulate the localization of a type I membrane protein between the ER, Golgi 
and PM (310).  These studies suggest that TM sequence length can act as a 
sorting determinant of some membrane proteins.   
The chemical character of the TM can also regulate the sorting of 
membrane proteins.  A computational analysis of golgi and PM membrane 
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proteins shows that the overall hydrophobicity of a TM sequence can regulate 
the sorting of proteins between the golgi and PM; the higher the hydrophobicity, 
the greater the likelihood the protein will sort to the PM (311).  Experimental 
evidence supports the computational analysis, showing that a replacement of 
nonhydrophobic a.a. in the middle of an ER membrane protein’s TM sequence 
with hydrophobic a.a. causes the protein to sort to the PM (312).  In addition to 
overall hydrophobicity, changing the polarity of the linear hydrophobicity gradient 
within the TM sequence of an ER membrane protein results in sorting of the 
protein to the PM (312).  The same study shows that altering the a.a. sequence 
flanking the TM sequence can also influence ER membrane protein sorting; 
mutating the positively charged or polar a.a. to hydrophobic a.a. results in the 
protein sorting to ER-Golgi intermediate transport vesicles.  The a.a. sequence 
characteristics used to predict the sorting and localization of most cellular 
membrane proteins do not apparently apply to proteins destined for the INM or 
ODV envelopes.  Figure 5 shows a summary and comparison of several INM 
proteins and the viral SM sequence.  This comparison shows that examples of 
both type I and type II membrane proteins can be found in the INM or the ODV 
envelope.  The proteins of these membranes can be anchored by internal TM 
sequences or N-terminal or C-terminal signal anchors.  Prediction of localization 
based on the length of the TM sequence also cannot be applied to these 
proteins, as the length varies from 18 to 22 a.a.  Infact, the nuclear pore 
membrane protein, POM121, has a predicted TM sequence of 44 a.a., yet spans  
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Figure 5.  Comparison of the E66 SM a.a. sequence with cellular INM proteins.  The TM 
and flanking sequences most likely to influence INM localization are shown.  Reprinted in 
accordance with Copyright ©1993-2004 by The National Academy of Sciences of the United 
States of America, all rights reserved (119).   
 
the membrane only once (313).  Hydrophobicity cannot be used to predict the 
localization: the overall hydrophobicity of the TM sequence varies greatly among 
the INM and ODV envelope proteins.  Additionally, cytoplasmic/nucleoplasmic 
domain size cannot be used to predict if a protein will be excluded from the INM 
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as the nesprin family of INM proteins contain a cyto/nucleoplasmic domain of 
one MDa (204).  However, there are features identified in the viral SM sequence 
that are apparently conserved among the known ODV envelope and INM 
proteins: a TM sequence (with a single or no polar a.a. and no charged a.a.) with 
a cluster of charged a.a. spaced 5-8 a.a. from the nucleoplasmic side of the TM.  
The goal of this study is to interrogate the conserved features of the viral SM to 
determine which features are essential and their role in protein sorting to the 
INM. 
Specific aims 
Hypothesis.  Sorting and localization of integral membrane proteins to the inner 
nuclear membrane can be mediated in part by the sorting motif sequence 
identified in AcMNPV ODV-E66.  
As described, the current model for sorting and localization of integral 
membrane proteins to the INM is “diffusion:retention”.  This model predicts: 
integral membrane proteins randomly diffuse within the continuous membranes 
of the ER and NE and once localized in the INM, the proteins are immobilized 
and retained through interactions with either immobilized nucleoplasmic ligands, 
and/or other resident INM proteins (195-198).  Therefore, immobilization in the 
INM is the only mechanism for sorting INM proteins at the INM.  The amino 
terminal 33 a.a. of ODV-E66, termed the sorting motif (SM) (Fig. 6), are 
sufficient for localization of GFP, β-gal fusions, or E66 to viral-induced 
intranuclear microvesicles and ODV envelopes during infection.  When 
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abundantly expressed, in addition to intranuclear microvesicles and ODV 
envelopes, the SM-fusion proteins are also detected in the INM, ONM and ER 
(152).  This localization pattern suggests that the SM-fusion proteins use a 
pathway similar to INM proteins to sort and localize to the INM, while viral-
specific events further sort these proteins to MV and ODV envelopes (151, 152).  
The chemical characteristics of the E66 derived SM are: 1) An 18 a.a. TM 
sequence (type I orientation) with no charged or polar a.a.; 2) A cluster of 
aromatic a.a. located at one end of the TM sequence; 3) A group of 5 polar a.a. 
at the C-terminal end of the TM sequence followed by 4) A cluster of charged 
a.a. spaced 6 a.a. residues from the last aromatic a.a. of the TM sequence.  A 
comparison of the E66 SM with cellular INM proteins shows most of the 
chemical features of the SM are conserved within the INM proteins whose 
sorting determinants have been identified (119) (the polar a.a. of the SM are not  
 
 
Figure 6.  Predicted functional features identified in the ODV-E66 SM and lamin B 
receptor. 
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conserved among the cellular INM proteins).  The primary goal of this study is to 
gain insights into the essential features of the SM or SM-like sequences in the 
sorting and localization of proteins to the INM or ODV envelope. 
What are the essential features of the ODV-E66 “sorting motif?” To 
determine which of the predicted features of the ODV-E66 SM are essential for 
sorting, directed mutations within the SM will be developed.  These mutations 
will remove or alter: 1) the aromatic a.a. of the TM; 2) the polar a.a.; and/or 3) 
the spacing a.a. residues separating the cluster of charged a.a. and the TM 
sequence of the SM (Fig. 6).  These SM mutants will be expressed as GFP 
fusion proteins.  In addition, comparative studies will be performed with LBR to 
determine if the cellular SM-like sequences sort proteins like the viral SM.  The 
LBR nuclear ligand-binding sequence and the N-terminal charged a.a. 
associated with the TM sequence in the first 238 a.a. of LBR will be deleted and 
the mutant LBR expressed as GFP fusions.  Intracellular localization, protein 
orientation and membrane association (in Sf9 cells) will be determined for all the 
SM- and LBR-fusion proteins.   
To further address if SM function correlates with the placement of 
presence of the charged a.a., one or more of the charged a.a. within the SM of 
E66 will be replaced with alanine or a different charged a.a.  Intracellular 
localization and membrane association of the mutant E66 protein in uninfected 
and infected Sf9 cells will be determined.   
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Are SM or SM-like sequences functional in vertebrate cells?  To determine if 
the SM is sufficient to sort fusion proteins to the INM of vertebrate cells, the E66 
SM-GFP and LBR-GFP fusions will be expressed in CHO-K1 cells and 
intracellular localization and protein orientation of the fusion proteins will be 
determined.   
Can sorting and localization to the inner nuclear membrane be 
independent of immobilization?  To determine if immobilization is required for 
concentration of proteins with SM or SM-like sequences in the INM, FRAP 
experiments will be performed to measure the mobility of the LBR- and SM-GFP 
fusion proteins in the INM and ER of CHO-K1 and Sf9 cells.   
Are viral SM sequences recognized differently than cellular SM-like 
sequences during infection?  During infection, viral envelope proteins localize 
to INM derived viral-induced microvesicles (MV) and ODV envelopes.  One 
could predict that if cellular INM proteins with SM-like sequences are 
immobilized in the INM of insect cells, then, during infection, these proteins 
should not localize in microvesicles/ODV envelopes.  However, if the resident 
INM proteins are mobile in the INM, and the only active sorting event at the INM 
is immobilization, then it is possible that these proteins will accumulate in MV 
and ODV envelopes.  To determine if cellular SM-like sequences are 
distinguished from the viral SM sequence, the LBR- and SM-fusion proteins will 
be expressed during infection and localization determined using light confocal 
and immunoelectron microscopy. 
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MATERIALS AND METHODS 
Plasmid cloning and DNA sequencing 
General plasmid cloning protocols are described by Sambrook et. al., 
(314).  Polymerase chain reaction (PCR) was performed using a MJ Research 
DNA Engine Peltier Thermal Cycler, PTC-200 (MJ Research, Inc., Reno, NV).  
DNA was transformed into strain DH5α E. coli cells by electroporation using a 
Bio-Rad Gene Pulser II (Bio-Rad Laboratories, Inc., Hercules, CA).  Double 
stranded DNA sequencing was performed using the ABI PRISM Big Dye 
Terminator Cycle Sequencing Core Kit with Amplitaq® DNA Polymerase.  
Sequencing reactions were analyzed using an ABI 373 XL or 377 XL DNA 
sequencer (Applied Biosystems Inc., Foster City, CA).  DNA was sequenced on 
both strands to check for errors using oligonucleotides appropriate for the 
specific clone.  Enzymes were purchased from either Promega (Madison, WI) or 
New England Bio-labs (Beverly, MA) unless otherwise noted. 
Cell culture and virus infection 
Spodoptera frugiperda IPLB-SF21 (315) clonal isolate 9 (Sf9) cells (16) 
were cultured as both suspension and adherent cultures at 27oC in TNM-FH 
medium supplemented with 10% FBS and 1.0% F-68 (Complete TNM-FH).  
AcMNPV strain E2 was used as the wild type (wt) control virus.  All infections 
were performed at a multiplicity of infection of 10, with time zero set at the time 
of virus addition.  A proline auxotroph clone of a Chinese Hamster Ovary cell line 
(CHO) (American Type Culture Collection, Manassas, VA, catalog number CCL-
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61), termed CHO-K1, was cultured as an adherent culture in Dulbecco’s 
Modified Eagle Medium (DMEM) (Invitrogen Corporation, Carlsbad, California) 
supplemented with 2 mM Proline, 10% FBS, and 3.7g/L NaHCO3 (37oC + 5.0% 
CO2 in a humidified incubator). 
Expression in uninfected Sf9 cells 
Expression studies were conducted using uninfected Sf9 cells with 
various DNA constructs.  Transfection of Sf9 cells was conducted using calcium 
phosphate transfection method described in Summers and Smith (83).  Briefly, 
Sf9 cells were seeded at a density of 1.0 x 106 cells per well in 6 well culture 
dishes.  After allowing attachment, the cells were washed with 2.0 ml Grace’s 
Antheraea medium (Graces) (316) + 10 % FBS leaving 0.75 ml of the medium 
on the cells.  Transfection mixes were prepared by adding 10 µg of pIE1 plasmid 
DNA containing the appropriate construct to 0.75 ml of transfection buffer 
(25mM HEPES, pH 7.1, 140 mM NaCl, 125 mM CaCl2).  The transfection mix 
was added to 1 well of cells drop wise, and the cells were incubated at 27oC for 
4 hours.  Following incubation, the cells were washed with 2.0 ml complete 
TNM-FH, and incubated with 2.0 ml complete TNM-FH at 27oC for 48 hours.   
Immunofluorescence confocal microscopy 
Infected (48 hours post infection, h p.i.) or transfected Sf9 cells were 
harvested.  The harvested cells were collected by centrifugation (500 x g, three 
minutes) and resuspended in Graces media and 2.8 x 105 cells were transferred 
to a one well cytofuge container (Statspin Technologies, Norwood, MA.) on an 
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Esco No. 2960 slide (Erie Scientific, Erie, PA).  After allowing attachment at 
room temperature (RT) for five minutes, the cells were fixed with 3.7% 
paraformaldehyde in PBS (phosphate buffered saline) at RT for 10 minutes.  
Following fixation, the cells were washed three times with PBS.  Following the 
washes, fixed cells were incubated with 100% Methanol (MeOH) for 10 minutes 
at RT followed by 0.5%Triton X-100 for 10 minutes at RT.  Following both 
incubations, the cells were washed as previously described, and incubated in 
blocking solution (1.0% porcine serum, 3.0% bovine serum albumin, PBS) for 
one hour at RT.  Primary antibodies were diluted in blocking solution, added to 
the fixed cells and incubated at 4oC for overnight.  The fixed cells were washed 
and incubated with secondary antibodies (Alexa Fluor conjugates, Molecular 
Probes, Inc., Eugene, OR) diluted at 1:2000 in blocking solution for two hours at 
RT.  Following incubation with secondary antibody, the cells were washed.  
When DNA staining was required, the cells were incubated with DAPI (4’, 6’ 
diamidino-2-phenylindole) diluted at 0.1 µg/ml in PBS for five seconds and 
washed three times in PBS.  Following the final washes, all solutions were 
removed, and 10 µl of DAKO Fluorescent Mounting Medium (DAKO 
Corporation, Carpinteria, CA) was added and covered with a number 1.5 1-
ounce cover slip (VWR, West Chester, PA, catalog number 48366 227).  Cover 
slips were sealed with nail hardener and stored in the dark at 4oC until ready for 
viewing.  Slides were viewed using a Zeiss Axiovert 135 (Carl Zeiss 
MicroImaging, Inc. Thornwood, NY) with a CARV confocal module (Atto 
59 
Bioscience, Rockville, MD).  After viewing at least 20 fields, representative 
cells/fields were collected using either the CARVer software (Atto Bioscience), or 
Zeiss Axiovision ver. 3.1 (Carl Zeiss MicroImaging, Inc., Thornwood, NY).  
Confocal sections were collected at 0.75 µm intervals and the section 
representing the middle of the cell shown in each case.  Three-dimensional 
reconstruction and image deconvolution was conducted using either Zeiss 
KS400, ver. 3.0 or Zeiss Axiovision ver. 3.1.   
CHO-K1 cell transfection and microscopy 
The DNA used for transfection of CHO-K1 cells was isolated using a 
Qiagen Endo Free Plasmid Maxi Kit (Qiagen, Inc., Valencia, CA, catalog number 
12362).  Transfection of foreign DNA constructs into CHO-K1 cells was 
accomplished using LipofectAmine® reagent following the manufacturer’s 
protocol (Invitrogen Corporation, Carlsbad, California, catalog number 18324-
012).  CHO-K1 cells were seeded at a density of 1.0 x 105 cells/well in a 6 well 
plate in complete DMEM and incubated overnight at 37oC.  The cells were 
washed with 2.0 ml of Opti-MEM® (Invitrogen Corporation, Carlsbad, California, 
catalog number 22600050) before adding the transfection mix.  Transfection mix 
was assembled by mixing 3.0 µg of plasmid DNA, 12.5 µl of LipofectAmine, and 
200 µl of Opti-MEM.  This solution was incubated for 30 minutes at RT and then 
diluted with 800 µl of Opti-MEM.  The dilute transfection mix was added to the 
washed cells and incubated overnight at 37oC.  Following incubation, the 
transfection mix was removed, and replaced with complete DMEM (time zero).  
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At 48 hours post transfection, the cells were detached by trypsinization, and 
reseeded onto chambered slides (Nalge Nunc International, Rochester, NY, 
catalog number 154461) at a density of 7.0 x 104 cells/well in DMEM and 
incubated overnight at 37oC.  Following transfection, the cells were processed 
for microscopy, and representative cells captured as previously described. 
Quantifying fluorescence from confocal images 
Utilizing a custom macro (Appendix A) written for Zeiss KS400, ver. 3.0, 
the amount of E66 fluorescence label in the intranuclear space, nuclear 
envelope, or the extra-nuclear space of infected cells was quantified.  A 
schematic of the macro is shown in figure 7.  This macro allows the user to load 
images of a specific confocal section corresponding to the three separate 
channels of fluorescence plus a brightfield image.  Briefly, the macro allows the 
user to trace the outside of the cell (from the brightfield image) to identify the 
plasma membrane. Once completed, the blue channel was used to identify the 
region directly beneath the nuclear envelope by allowing the user to trace 
fluorescence label.  Once the trace was complete, the software identified the 
nuclear envelope and segregated this region from the intranuclear and extra-
nuclear space.  Once completed, the software then calculated the total 
fluorescence intensity units (grey values) per cell, the total fluorescence intensity 
units in each region, as well as the total area/pixel2 and total area/pixel2 for each 
region.  The blue channel of fluorescence corresponded to the lamin antibody 
label [Adl67, (242)].  The green channel of fluorescence corresponded to the  
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Figure 7.  KS400 macro schematic.  Schematic drawing of the macro used for regional 
quantitation experiments. EN-extranuclear, NE-nuclear envelope, IN-intranuclear. 
 
GFP auto fluorescence.  The red area/pixel2 and total area/pixel2 for each 
region.  The blue channel of fluorescence corresponded to the lamin antibody 
label [Adl67 (242)].  The green channel of fluorescence corresponded to the 
GFP auto fluorescence.  The red channel of fluorescence corresponded to the 
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label of the quantified protein.  For each cell, only those sections that displayed 
a prominent rim of fluorescence around the nucleus when viewing the lamin 
label were quantified. Once the raw quantitation was accomplished by KS400, 
the data was imported to Microsoft Excel for analysis.  To analyze, the sum of 
the fluorescence intensity units per each region for each section was calculated, 
along with the area/pixel2 per each region for each section.  Following those 
calculations, the percentage of label and the percentage of area for each section 
were calculated.  A density ratio was calculated by dividing the percentage of 
fluorescence intensity units per region by the percentage of area/pixel2 per 
region (% grey/% area) for each cell.  For each construct tested, the 
fluorescence of 7-10 cells was quantified, and the density ratios were used to 
calculate an average density ratio for each fusion protein tested.  These average 
ratios were normalized to 100% for each fusion protein tested, and plotted on a 
bar graph using Microsoft Excel.  Error bars represent standard deviation for the 
noted number of determinations (n). 
Assay of membrane protein integration by Triton X-114 extraction  
Triton X-114 extractions assays were performed as described by Bordier 
et al. (317) and Rosenberg et al. (318).  Briefly, 2.0 ml of Triton X-114 (Fluka, 
Buchs SG, Switzerland) was pre-cleared with 100 ml of PBS, pH 7.0 resulting in 
a ~11.4% v/v Triton X-114 solution, this solution was used as the stock Triton X-
114 throughout the experiment.  Transfected or infected (48 h p.i.) Sf9 cells 
(~5.0 x 106) or transfected CHO-K1 cells (~5.0 x 106) were collected by 
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centrifugation (500 x g, three minutes).  The cell pellet was resuspended in 1.0 
ml of lysis buffer (1.0% Triton X-114, PBS) and incubated with agitation at 4oC.  
The solution was cleared by centrifugation (16,000 x g, 10 minutes), and the 
supernatant loaded on a100 µl sucrose cushion (6.0%sucrose, 0.06% Triton X-
114 in PBS).  Following incubation at 37oC for 3 minutes, the phases were 
separated by centrifugation (500 x g, three minutes) at 37oC.  Following 
centrifugation, the aqueous and detergent phases were separated into separate 
fractions.  The aqueous fraction was re-extracted with 50 µl of the 11.4% Triton 
X-114 stock, and the detergent fraction was re-extracted with 1.0 ml PBS.  Each 
fraction was incubated and centrifuged as previously described to separate the 
phases.  Only the aqueous phase was saved after re-extracting the initial 
aqueous fraction and only the detergent phase was saved after re-extracting the 
initial detergent fraction. The final extracted fractions were adjusted to 1.0 ml 
with PBS. An equal volume of SDS-PAGE sample buffer (4% w/v SDS, 10% v/v 
Glycerol, 0.50 mM Tris, 2.0% β-mercapthoethanol, 0.04% Bromophenol blue, pH 
6.8) was added to each sample and incubated at 65oC for 15 minutes.  
Following SDS-PAGE (35 µl of the total sample) and western transfer, the 
samples were analyzed by incubating the immunoblot with the appropriate 
antibodies. 
Digitonin permeabilization assay for INM localization  
Digitonin permeabilization was utilized as described in Adam et al. (319).  
The protocol was slightly modified for Sf9 cells.  Briefly, transfected Sf9 cells 
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(~2.8 x 105) were re-seeded in 1 well cytofuge container (Statspin Technologies, 
Norwood, MA.) on an Esco No. 2960 slide (Erie Scientific, Erie, PA).  After 
allowing attachment for one hour a RT, the cells were washed three times with 
Graces media and fixed with 3.7% paraformaldehyde (PBS) for 10 minutes (RT).  
Fixed cells were washed three times with PBS, and incubated with 30 µg/ml 
digitonin (Calbiochem, La Jolla, CA; PBS) for 10 minutes at RT.  The cells were 
washed with PBS, and incubated with blocking solution (RT, 10 minutes).  
Following the incubation, the fixed cells were incubated with primary and 
secondary antibodies as previously described for immunofluorescence 
microscopy.  For CHO-K1 cells, the protocol was modified as described in Wu et 
al. (231).  Transfected cells were washed three times in PBS, and fixed in 2.0% 
paraformaldehyde (PBS) for 30 minutes on ice.  The cells were washed three 
times with PBS and incubated with pre-cooled digitonin, diluted to 40 µg/ml 
(PBS), for 10 minutes on ice.  The cells were washed three times with PBS and 
incubated with blocking solution (RT, 10 minutes).  Following the blocking 
reaction, the fixed cells were incubated with primary and secondary antibodies 
as previously described for immunofluorescence microscopy. 
Fluorescence recovery after photo-bleaching 
DNA was transfected into CHO-K1 or Sf9 cells as previously described, 
however, the cells were not fixed or exposed to antibodies.  Prior to the day of 
FRAP experiments, the cells were transferred to number 1 chambered cover 
glasses (Nalge Nunc International, Rochester, NY, catalog number 155380).  
65 
The transfected Sf9 cells (1.0 x 105 cells/well) or CHO-K1 cells (7.0 x 104 
cells/well) were allowed to attach overnight under normal culture conditions.  If 
DNA staining was required the cellular DNA was stained for five minutes using 
Hoechst 33342 (Molecular Probes, Inc., Eugene, OR, catalog number H-3570) 
diluted to 0.1 µg/ml (PBS).  Following staining, the cells were washed three 
times with PBS followed by incubation with complete medium.  Prior to viewing, 
the cells were washed once [Sf9; Graces medium + 10%FBS, CHO-K1; 
Leibovitz L-15 Medium (Invitrogen Corporation, Carlsbad, CA, catalog number 
21083027)] with 2.0 ml of the medium left on the cells.  The FRAP algorithm was 
used to achieve photo-bleaching of either the NE or ER (1.3 µm spot) of a cell 
with the scanning laser strength adjusted to 300 microwatts and photo bleaching 
laser strength set at two milli-watts. Following bleaching, the area was scanned 
every three seconds for up to four minutes and fluorescence recovery was 
recorded over time.  Lateral mobility in cell membrane was then computed 
according to the method of Yguerabide et al. (320). 
Protein orientation using an in vitro glycosylation assay 
Orientation of the LBR-fusion proteins in insect and mammalian cell 
membranes was determined using an in vitro glycosylation assay (321, 322).  
This assay involved in-vitro translation in the presence of microsomal 
membranes followed by determination of glycosylation state.  All mRNAs were 
transcribed from PCR generated templates using the AmpliCap™ SP6 High 
Yield Message Maker Kit (Epicentre Technologies).  In vitro translation was 
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performed using rabbit reticulocyte lysate (Promega) labeling the protein with 
35S-methionine (MP Biomedicals).  To generate the mRNAs for the LBR-GFP 
fusions with amino-terminal NST sequences, oligonucleotides were designed to 
generate templates that had the SP6 promoter, a Kozak consensus sequence, 
an ATG start codon, and a consensus glycosylation acceptor sequence (NST) 
on the 5’ end of the coding sequence.  If spacer a.a. were required (200-238LBR, 
208-238LBR), they were added between the NST and the start of the gene coding 
sequence.  To add the carboxy terminal NST and required spacer a.a., PCR was 
used to generate LBR gene sequences with a 5’ SP6 promoter and Kozak 
sequence, and a 3’ NST and required spacing sequences.  The final sequences 
of the engineered proteins are shown in the figure (pg. #).  In vitro translation 
reactions were performed in the presence or absence of canine (Promega) or 
Sf9 cell derived microsomal membranes.  For each construct, one translation 
reaction containing microsomes was incubated with endoglycosidase H (New 
England Biolabs; manufacturers instructions).  The proteins were separated 
using SDS-PAGE and the translated product viewed by autoradiography.  Sf9 
derived microsomal membranes were isolated as reported in Saksena et al. 
(323). Sf9 cells were collected by centrifugation (1,200 x g, 10 minutes) and 
diluted with 4.0 ml per gram of cell mass in buffer A [50 mM TEA (pH 7.5), 50 
mM KOAc, 6 mM Mg(OAc)2, 1.0 mM EDTA, 1.0 mM DTT, and 0.5 mM PMSF].  
The resuspended cells were homogenized with 10 strokes using a motor driven 
drill homogenizer, avoiding foam formation and heating. This homogenate was 
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centrifuged (1,000 x g, 10 minutes) and the supernatant re-centrifuged (10,000 x 
g, 10 minutes).  Microsomes were collected by centrifugation of the 10,000 × g 
supernatant (140,000 x g, 2.5 hours) through a 1.3 M sucrose cushion (buffer A).  
Microsome pellets were resuspended in buffer B [250 mM sucrose, 50 mM TEA 
(pH 7.5), and 1 mM DTT] by manual dounce homogenization to a concentration 
of 50 A280 units/ml (1 equivalent/ml).  The microsomes were considered 
competent if they targeted and translocated pre-prolactin (rabbit reticulocyte 
lysate) at levels comparable with canine microsomes.  In addition to the 
glycosylation assay, orientation was also confirmed using protease protection 
following the protocol of Hong et al. (148). 
SDS-PAGE, western and immunoblotting   
Sodium dodecyl sulfate polyacrylamide gel electrophoresis, SDS-PAGE, 
was performed as described by Laemmli (324).  Unless otherwise stated a 
12.5% separating gel with 3.0% stacking gel was used.  Samples were 
denatured using an equal volume of 4x SDS-PAGE sample buffer and incubated 
at 65oC for 15 minutes.  Following electrophoresis, gels were either stained with 
Commassie blue (0.1%Comassie R-250, 10%MeOH) and destained/fixed (45% 
Acetic Acid, 10%MeOH), or transferred to Immobilon-P membrane (Millipore, 
Billerica, MA, catalog number IPVH 000 10) using the tank transfer method 
(314).  Blots were analyzed by incubating in blocking solution (3% nonfat dry 
milk, 50 mM Tris-HCL, 150 mM NaCl, 0.05% Tween 20, pH 7.4) for 30 minutes 
at RT, then incubated with primary antibody (diluted in blocking solution) for 
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either two hours at RT, or overnight at 4oC.  Blots were washed three times (5 
minutes per wash, RT) with TBS-T (50 mM Tris-HCl, 150 mM NaCl, 0.05% 
Tween 20, pH 7.4), followed by incubation with secondary antibody conjugated 
to horseradish peroxidase (HRP) (1:10000, blocking solution; 1hour, RT).  The 
blots were washed four times with TBS-T, and developed using the Western 
Lightning™ chemiluminescence reagent kit (Perkin Elmer, Boston, MA, NEL100) 
and Kodak X-Omat Blue XB-1 film (Eastman Kodak Company, New Haven, CT). 
DNA constructs 
∆XbaI, NarI pUC18 (Appendix B1, page 162).  Numerous constructs were 
developed using a modified version of the pUC 18 vector.  This modified version 
lacks the restriction enzyme recognition sites, NarI (bp235) and XbaI (bp423).  
Both of these sites were removed by first digesting with the appropriate enzyme, 
then filling the resulting overhangs with T4 DNA polymerase to generate blunt 
ends.  The digested/filled DNA vector was ligated and amplified.  The NarI site 
was destroyed first, generating ∆NarI pUC18. This modified pUC was digested 
to destroy the XbaI site generating ∆XbaI, NarI pUC18.   
∆XbaI, NarI pUC18 EGFP/Alt. EGFP (Appendix B2, page 163).  Enhanced 
green fluorescent protein (EGFP) (BD Biosciences Clontech, Palo Alto, CA) 
fusions were utilized throughout this study.  To generate the fusion protein 
constructs, restriction enzyme sites had to be added in frame to EGFP.  In 
addition, a variant of EGFP that lacked the charged amino acids between a.a. 2-
7 was designed and constructed (Alt. EGFP).  For subsequent cloning, the 
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restriction enzyme sites BamHI, XbaI, and NarI (5’ to 3’) were added to the 5’ 
end of the EGFP/Alt. EGFP DNA sequence.  PCR was utilized for the addition of 
the sites and for the modifications to EGFP (Appendix B2).  The PCR products 
were cloned into ∆XbaI, NarI pUC18 using the BamHI sites.  The two resulting 
clones are termed ∆XbaI, NarI pUC18 EGFP and ∆XbaI, NarI pUC18 Alt. EGFP 
(Appendix B2). 
Sorting motif scanning constructs (Appendix B3, page 164).  To dissect the 
essential features required for INM localization of the E66 sorting motif (SM), a 
series of EGFP fusion proteins were generated (Fig. 8).  Mutations in the coding 
sequence of the E66 SM fused to EGFP were constructed using complementary 
oligonucleotides (Appendix B3) cloned into the XbaI and NarI sites of the ∆XbaI, 
NarI pUC18 EGFP/Alt. EGFP vectors.  Complementary oligonucleotides were 
annealed by mixing equimolar amounts of each oligonucleotide, incubating at 
95oC for 5 minutes, and then cooling to room temperature at 0.1oC per second.  
Constructs “A” and “B” are native E66 sequences, and constructs “C” and “D” 
have the aromatic a.a. codons replaced with a leucine codon.  Constructs “A” 
and “C” were fused to the EGFP sequence, whereas, constructs “B” and “D” 
were fused to Alt. EGFP (Appendix B3).  For expression in uninfected Sf9 insect 
cells, the constructs were inserted in the BamHI site of pIE1-3 (Novagen, 
Madison, WI, catalog number 69090-3).  To production of recombinant 
baculovirus, the constructs were inserted in the BamHI site of pBACgus-1 
(Novagen, Madison, WI, catalog number 70054-3).  Finally, for mammalian cell 
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expression, the constructs were placed into the BamHI site of pcDNA3.1/Zeo(+) 
(Invitrogen Corporation, Carlsbad, CA, catalog number V860-20). 
 
A.a.:    1                                                18         25                 33  
E66  MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAFID – E66 
SM1A  MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAGAM – EGFP 
SM1C  MSIVLIIVIVVILLICLLLLSNSNNKNDANKNNAGAM - EGFP 
SM2A  MSIVLIIVIVVIFLICFLYLKNDANKNNAGAM – EGFP 
SM2C  MSIVLIIVIVVILLICLLLLKNDANKNNAGAM – EGFP 
SM3A/B MSIVLIIVIVVIFLICFLYLSNSNNAGAM – EGFP/Alt.EGFP 
SM3C/D MSIVLIIVIVVILLICLLLLSNSNNAGAM – EGFP/Alt.EGFP 
SM4A/B MSIVLIIVIVVIFLICFLYLAGAM – EGFP/Alt.EGFP 
SM4C/D MSIVLIIVIVVILLICLLLLAGAM – EGFP/Alt.EGFP 
∆CSM1A MSIVLIIVIVVIFLILFLYLSNSNNKNDANKNNAGAM – EGFP 
Figure 8.  A.a. sequence resulting from the sorting motif mutations.  The transmembrane 
sequences are shown in red. The aromatic a.a. or the leucines substituted in their place are 
bolded.  The polar a.a. are shown in blue.  The charged cluster of a.a. is shown in purple. The 
EGFP of Alt.EGFP sequences are shown in green.  The leucine substituting the cysteine in ∆C 
SM1A is underlined. 
 
Charge mutations in full length E66 (Appendix B4, page 166).  Several 
constructs were built that mutated the codons encoding the charged a.a. of the 
SM within the full length E66 gene (Fig. 9 for final a.a. sequence).  PCR 
(Appendix B4 for the oligonucleotides) was utilized to generate the E66 gene 
sequence with the charge mutations.  Following PCR amplification, the mutated 
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E66 genes were cloned into the SacI/MluI sites of a pGEM-4z construct 
containing E66 which lacks the coding sequence for the amino terminal 33 a.a. 
These charge mutated constructs were cloned into the BamHI sites of pIE1-3, 
pBACgus-1, and pcDNA3.1/zeo (+).   
 
   A.a.:  1                                                                                             37           704 
E66  MSIVLIIVIVVIFLICFLYLSNSNNKNDANKNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNGNGANGNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNANAANANNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNKNKANKNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNDNDANDNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNANDANKNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNKNDANANNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNANDANANNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNRNDANRNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNKNEANKNNAFID – E66 
E66  MSIVLIIVIVVIFLICFLYLSNSNNRNDANRNNAFID – E66 
Figure 9.  N-terminal sequence of E66 with mutated charge residues.  The mutated a.a. of 
the SM are shown in bold. 
 
N-terminal 125 a.a. of E66 with the SM charge mutations fused to EGFP 
(Appendix B5, page 168).  PCR (Appendix B5 for oligonucleotides) was utilized 
to amplify the sequence of the first 125 amino acids from the pGEM E66 genes 
containing the directed mutations at the charged a.a. described in appendix B4 
(a schematic of the clones is shown in figure 10).  The products were placed into 
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the XbaI/NarI sites of ∆XbaI, NarI pUC19 EGFP (Appendix B5).  Once sequence 
confirmed, the 125 E66 EGFP clones were digested with BamHI, and the 
fragments ligated into the BamHI site of pIE1-3. 
 
 
Figure 10.  Schematic of the N-terminal 125 a.a. of E66 with the SM charge mutations 
fused to EGFP. 
 
Mammalian expression of the sorting motif (Appendix B6, page 169).  For 
expression in mammalian cells, a consensus Kozak sequence (325) was added 
5’ of the initiator methionine codon of the SM-GFP constructs using PCR 
(forward oligo – 125FW (ori), Appendix B6,  reverse oligo – EGFP reverse, 
Appendix B2).  Once amplified, the PCR products placed into the AflII/BamHI 
sites of pcDNA3.1/Zeo (+) (Appendix B6).   
Lamin B receptor.  Three lamin B receptor (LBR) clone constructs (Fig. 11) 
were used in this study.  The first construct, phLBR 1TM-EGFP  
(1-238LBR-GFP) (199), construct obtained from Jan Ellenberg (European 
Molecular Biology Laboratory, Heidelberg, Germany).  This construct contains 
the cDNA sequence for a.a. 1-238 of LBR fused to EGFP and includes the N-
terminal nuclear ligand-binding sequence as well as the first transmembrane 
domain.  This fusion construct was excised and inserted into the BamHI/NotI 
sites of pIE1-3 (insect expression), pGEM-4z (in vitro transcription), and 
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pBACgus (recombinant baculovirus).  Two additional LBR base constructs 
containing deletions in the N-terminal a.a. were generated using PCR (Appendix 
B7, page 166).  The first construct lacked the sequence encoding the nuclear 
ligand-binding sequence of LBR (200-238LBR-GFP, Fig. 11B), while the second 
construct lacked the nuclear ligand-binding sequence and the sequence 
encoding the charged a.a. flanking N-terminal side of the transmembrane 
sequence (208-238LBR-GFP, Fig. 11C) (Appendix B7 for oligonucleotides).  The 
PCR generated products were inserted into the BamHI/HindIII sites of pUC18.  
Both constructs were then cloned into the BamHI/HindIII sites of the mammalian 
expression vector, pCMVBlue (Pharmingen, San Diego, CA).  Additionally, each 
construct was cloned into the BamHI/NotI sites of pIE1-4 (insect expression, 
Novagen, Madison, WI, catalog number 69090-3) and pBACgus-1 (recombinant 
virus).   
 
 
Figure 11.  Schematic of LBR-GFP base constructs.  A.) The phLBR 1TM-EGFP clone 
obtained from J. Ellenberg.  B.) The LBR-GFP fusion generated lacking the nucleoplasmic 200 
a.a. of phLBR 1TM-EGFP.  C.)  The LBR-GFP fusion generated lacking the nucleoplasmic 208 
a.a. of phLBR 1TM-EGFP.  
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Figure 12.  Schematic of T71-238LBR-GFP construct. 
 
For expression in mammalian cells, a consensus Kozak sequence (325) 
was added 5’ of the initiator methionine codon of the N-terminal deleted LBR-
EGFP fusions (oligonucleotides and clone map, Appendix B8, page 167).  The 
PCR products were inserted into the BamHI/NotI sites of pcDNA3.1/Zeo(+).   
 Digitonin permeabilization assays required that the 1-238LBR-GFP fusion 
have a unique epitope tag at the N-terminus (Fig. 12).  PCR (clone map and 
forward oligonucleotides, Appendix B9, reverse oligonucleotides, Appendix B8) 
was used to generate the cDNA encoding T71-238LBR-GFP (Appendix B9, page 
168). This PCR product was cloned into the BamHI/NotI sites of 
pcDNA3.1/Zeo(+) and pIE1-4 for mammalian and insect cell expression 
respectively.  
Recombinant virus production 
Recombinant virus expressing the sorting motif fusion proteins. To 
develop recombinant viruses that expressed the SM-GFP constructs (figure 7) 
under control of the polyhedrin promoter, the pBACgus SM clones were co-
transfected with Bsu361 digested BacPak AcMNPV genomic DNA (gift of Robert 
D. Possee, Center for Ecology and Hydrology, University of Oxford, Oxford, UK) 
as described in Summers and Smith, (83).  Recombinant virus was selected 
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through three rounds of plaque assay and positive plaques were detected using 
the chromagen X-gluc [40 mg/ml X-gluc (5-bromo-4-chloro-3-indolyl β-D-
glucopyranoside); incubated at RT for 4-8 hours for the chromagenic reaction].  
Blue plaques were picked into 500 µl of complete TNM-FH, vortexed for 30 
seconds and incubated at RT for 1 hour.  Passage 1 virus was generated from 
the third round plaques by inoculating 1.0 x 106 cells in a final volume of 2.0 ml 
with 100 µl of the viral stock.  Infections proceeded for 7 days at 27oC and the 
media supernatant collected to harvest recombinant virus.  PCR was used to 
verify that each recombinant virus had the appropriate SM-GFP clone inserted 
into the polyhedrin locus.  Briefly, 750 µl of the passage 1 virus stock was mixed 
with an equal volume of precipitation solution (20% polyethylene glycol, 8000 
MW and 1M NaCl) and centrifuged at 16,000 x g for 20 minutes at room 
temperature.  The supernatant was removed, the pellet resuspended in 100 µl of 
disruption buffer (10mM Tris, 1mM EDTA, 0.25% SDS, pH 7.6, 1.0 mg 
proteinase K) and incubated overnight at 37oC.  Following incubation, 
phenol:chloroform (1:1) extraction was performed and centrifugation (1,200 x g) 
used to separate the phases.  The viral DNA was precipitated from the aqueous 
phase and resuspended in 10 µl of sterile water.  PCR was performed using 5.0 
µl of the purified viral DNA [forward oligonucleotides: SM4A sense strand 
(Appendix B3), reverse oligonucleotides: EGFP reverse (Appendix B2)].  
Production of a ~900 bp product verified the insertion of the appropriate SM-
GFP fusion into the polyhedron locus.  
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Recombinant virus expressing the lamin B receptor fusion proteins.  Lamin 
B receptor recombinant viruses were constructed using the pBACgus-1 Lamin B 
receptor clones (Fig. 11).  Techniques to produce the virus were the same as for 
the recombinant viruses expressing the SM fusions.  PCR verification was done 
using EGFP forward and EGFP reverse (Appendix B2).  
 
Antibodies.  The antibodies used in this study are listed in table 3. 
 
Table 3 – Antibodies used for dissertation study 
 
Antibody Company/Researcher Location Catalog 
Number 
Dilution 
Nuclear Pore 
(mAB414) 
Berkley Antibody Company Richmond, 
CA 
MMS-120P 1:500 
(microscopy) 
Calreticulin Affinity Bioreagents Golden, CO PA3-900 1:500 
(microscopy) 
GFP Molecular Probes Eugene, OR A11122 1:1000 
(immunoblotting) 
1:500 
(microscopy) 
GFP Rockland Gilbertsville, 
PA 
600-101-215 1:2500 
(immunoblotting) 
GFP Chemicon International Temecula, CA AB16901 1:1000 
(microscopy) 
Calnexin Stressgen Biotechnologies Victoria, BC 
Canada 
SPA-860 1:1000 
(immunoblotting) 
1:500 
(microscopy) 
Lamin Paul Fisher, Southern 
University of New York 
Stony Brook, 
NY 
ADL 67 
(242) 
1:500 
(microscopy) 
ODV-E66 Max D. Summers, Texas 
A&M University 
College 
Station, TX 
ODV-E66 
(148) 
1:2500 
(immunoblotting) 
1:1000 
(microscopy) 
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RESULTS 
 
The essential features of the ODV-E66 sorting motif  
To determine the essential features of the SM, fifteen E66 SM-GFP fusion 
proteins containing mutations within the SM sequence were constructed (Fig. 
13).  These fusions proteins were expressed under the IE1 promoter in 
uninfected insect cells and expressed under the polyhedrin promoter in infected 
insect cells.  These SM fusions: 1) Mutated the aromatic a.a. to leucines; 2) 
Mutated the cysteine to leucine; 3) Removed the cluster of polar a.a.; 4) 
Removed the cluster of charged a.a. in the SM; 5) Removed the EGFP N-
terminal charged a.a.; and/or 6) Shortened the SM transmembrane sequence.  
EGFP was altered to remove the N-terminal charged a.a. and is termed Alt. 
EGFP.  Cells expressing these SM fusions were imaged using light confocal 
microscopy.  Antibodies directed against the soluble endoplasmic reticulum (ER) 
protein, calreticulin, were used as a marker to identify ER, and the DNA stain, 
DAPI, was used to identify the nucleus.  In addition, membrane association of 
the mutated SM-GFP fusions was assayed using Triton X-114 extraction. 
When expressed in uninfected cells, the SM fusion proteins pattern of 
localization allowed for the classification of each fusion into one of four groups.  
When the control GFP protein was expressed in Sf9 cells, it localized  uniformly 
throughout the nucleus and the cytoplasm (Fig. 14).  This pattern of localization 
allowed for the conclusion that the specific localization of the SM-GFP fusion  
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Figure 13.  Fusion proteins generated to identify the minimal functional features of the 
ODV-E66 sorting motif. The TM sequence is denoted with a red bar and text, the aromatic a.a. 
are black and bolded, the polar a.a are blue and underlined, the C to L mutation of ∆C SM1A is 
black, bolded and underlined, and the GFP sequence is in green.  Mutations within the clones 
are noted as follows:  1) Aromatic a.a. mutated to leucines; 2) Cysteine mutated to leucine; 3) 
Cluster of polar a.a  removed; 4) Cluster of charged a.a. within the SM removed; 5) EGFP N-
terminal charged region removed; and/or 6) SM transmembrane sequence shortened. 
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proteins could be attributed to the fused SM sequence(s).  
When the WT SM sequence was fused to GFP (SM1A) and expressed in 
uninfected cells, it was detected colocalizing with the ER marker calreticulin and 
also showed a pronounced nuclear rim of fluorescence (Fig 14).  This GFP 
fusion, and the GFP fusion proteins which showed a similar pattern of 
localization were all classified in Group I.  These Group I fusion proteins 
included the SM fusions which mutated: 1) the aromatic amino acids to leucine; 
2) the cysteine to a leucine; or 3) removed the polar amino acids of the SM.  In 
each case the spacing from the C-terminus of the TM sequence to a charged 
amino acid remained 5 residues. The Group II SM fusion proteins were also 
detected colocalizing with calreticulin and showed a pronounced nuclear rim.  
However, the relative ratio of protein detected in the cytoplasmic membranes 
was higher in the cells expressing the Group II fusion proteins (Fig 15).  These 
fusion proteins increased the distance from the C-terminus of the TM sequence 
to the first charged amino acid.  Furthermore, in the case of SM3B and SM3D, 
the first charged amino acid was changed from a lysine to a glutamic acid.  The 
Group III SM fusions showed no pronounced fluorescent nuclear rim, but instead 
these fusions were detected either in the plasma membrane (SM4B) or in the 
ER (SM4D) (Fig. 16).  These fusion proteins likely increased the length of the 
TM sequence and changed the first charged amino acid from a lysine to a 
glutamic acid .  The Group IV SM fusion proteins also showed no fluorescence 
rimming the nucleus but instead were detected only colocalizing with the ER  
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Figure 14.  Confocal microscopy images of the Group I SM-fusion proteins expressed in 
uninfected Sf9 cells.  Calreticulin is shown as red, the GFP fusion is shown as green, DAPI is 
shown as white, and a merge of the three images is shown as “merge,” with the DAPI image re-
colored blue for contrast.  
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Figure 15.  Confocal microscopy images of the Group II SM-fusion proteins expressed in 
uninfected Sf9 cells.  Calreticulin is shown as red, the GFP fusion is shown as green, DAPI is 
shown as white, and a merge of the three images is shown as “merge,” with the DAPI image re-
colored blue for contrast.  
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Figure 16.  Confocal microscopy images of the Group III SM-fusion proteins expressed in 
uninfected Sf9 cells.  Calreticulin is shown as red, the GFP fusion is shown as green, DAPI is 
shown as white, and a merge of the three images is shown as “merge,” with the DAPI image re-
colored blue for contrast. 
 
 
Figure 17.  Confocal microscopy images of the Group IV SM-fusion proteins expressed in 
uninfected Sf9 cells.  Calreticulin is shown as red, the GFP fusion is shown as green, DAPI is 
shown as white, and a merge of the three images is shown as “merge,” with the DAPI image re-
colored blue for contrast. 
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Figure 18.  Triton X-114 extraction studies.  A.) Triton X-114 extraction of uninfected cells 
expressing the modified SM fusion proteins.  B.) Triton X-114 extraction of infected cells 
expressing the modified SM fusion proteins.  The modified SM fusions were detected on western 
blot using GFP antibodies.  For each designation, “A” represents the aqueous phase from the 
extractions, and “D” represents the detergent phase.  “Secretion” in panel A shows the results 
from an immuno-precipitation of the media from transfected cells using GFP antibodies from 
rabbit, and detected using GFP antibodies from goat.  These film images were cropped and 
reordered to show the data in a logical sequence.  No data was omitted by cropping. 
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marker (Fig.17).  These fusion proteins were mutated to include polar amino 
acids in the TM sequence, and shortened the distance from the C-terminus of 
the TM sequence to the first charged amino acid. 
Extraction of cells with Triton X-114 fractionates the proteins into either an 
aqueous or detergent phase.  Proteins that fractionate in the aqueous phase are 
likely soluble or peripheral membrane proteins, while proteins that fractionate 
with the detergent phase are likely integral membrane proteins.  Since this 
extraction procedure uses physiological concentrations of salt, peripheral 
membrane proteins that interact with an integral membrane protein via 
electrostatic interactions may fractionate with the integral membrane proteins.  
The results of the Triton X-114 extractions of uninfected cells expressing the SM 
fusions showed the Group I and II fusion proteins fractionated in the detergent 
phase (Fig. 18A) suggesting these fusions were integral membrane proteins.  
The Group IV fusion proteins fractionated in the aqueous fraction (Fig. 18A, see 
dot) suggesting they were peripheral membrane proteins.  The Group III fusion 
proteins were not detected in the extraction assays.  Immuno-precipitation of the 
culture media from cells expressing the Group III fusion proteins with GFP 
antibodies showed that these fusion proteins were secreted (Fig. 18A).   
The results from uninfected cells show that the aromatic a.a., the cysteine 
within the TM sequence and/or the polar a.a. did not significantly influence the 
accumulation of the SM-fusions in the NE.  However, altering the distance from 
the C-terminal end of the TM sequence to the first charged amino acid, and/or 
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changing the first charged amino acid from a residue with a net positive charge 
to one with a net negative charge altered the relative ratio of protein detected in 
the cytoplasmic membranes versus that detected in the nuclear rim.  
Furthermore, altering the length or chemical character of the TM sequence may 
also alter the localization of the SM-GFP fusion protein.  Therefore, these results 
showed that the essential features of the SM required for NE localization in 
uninfected cells (defined by a pronounced fluorescent nuclear rim) are a TM 
sequence of 18 amino acids (lacking polar and charged a.a.) with a cluster of 
charged a.a. spaced 5 residues from the end of the TM sequence (Fig. 19).     
 
 
Figure 19.  The essential features of the SM as determined by expression and detergent 
extraction studies in uninfected cells. 
 
These SM fusions were also expressed during infection.  Localization was 
determined using light confocal microscopy and association with the membranes 
(integral or peripheral) was determined using Triton X-114 extractions.  In 
infected cells expressing the SM fusion proteins, lamin antibodies (Adl67) were 
used to show the boundary of the nucleoplasm, and the DNA stain, DAPI, was 
used to identify DNA enriched regions within the nucleus. 
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Figure 20.  Confocal microscopy images of the Group I SM-fusion proteins expressed in 
infected cells.  Lamin is shown as red, the GFP fusion is shown as green, DAPI is shown as 
white, and a merge of the three images is shown as “merge,” with the DAPI image re-colored 
blue for contrast. 
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Figure 21.  Confocal microscopy images of the Group II SM-fusion proteins expressed in 
infected cells.  Lamin is shown as red, the GFP fusion is shown as green, DAPI is shown as 
white, and a merge of the three images is shown as “merge,” with the DAPI image re-colored 
blue for contrast. 
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Figure 22.  Confocal microscopy images of the Group III SM-fusion proteins expressed in 
infected cells.  Lamin is shown as red, the GFP fusion is shown as green, DAPI is shown as 
white, and a merge of the three images is shown as “merge,” with the DAPI image re-colored 
blue for contrast. 
 
 
Figure 23.  Confocal microscopy images of the Group IV SM-fusion proteins expressed in 
infected cells.  Lamin is shown as red, the GFP fusion is shown as green, DAPI is shown as 
white, and a merge of the three images is shown as “merge,” with the DAPI image re-colored 
blue for contrast.  
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The Group I and Group II GFP fusion proteins showed similar fluorescent 
patterns in infected cells; the proteins were detected within the nucleus.  The 
fluorescent patterns were similar to those reported for ODV envelope proteins 
and/or SM-GFP (148, 152).  This pattern of localization suggested the Group I 
and II SM fusion proteins localized in the viral-induced intranuclear microvesicles 
and ODV envelopes (Fig. 20, 21).  Triton X-114 extraction data showed that 
these fusion proteins fractionated mostly with the detergent phase, therefore, 
suggesting the Group I and II fusion proteins were integral membrane proteins 
(Fig 18B).  In infected cells, the Group III fusion proteins were detected mostly in 
the cytoplasmic membranes (Fig. 22) with some protein detected in the nucleus.  
For the two Group III fusion proteins, the majority of the protein fractionated with 
the detergent phase suggesting that the Group III fusions were integral 
membrane proteins (Fig. 18B).  Since the Group III fusion proteins were readily 
detected in the cytoplasmic membranes of infected cells, studies to determine if 
these proteins were secreted during infection were not conducted.  The Group 
IV proteins also localized mostly in the cytoplasmic membranes of the infected 
cells (Fig 23).  The Group IV fusion proteins fractionated mostly in the aqueous 
phase when extracted with Triton X-114 (Fig. 18B), suggesting that they were 
peripheral membrane proteins.   
 The features of the SM required for localization within the nucleus of 
infected cells were apparently different than the features required for NE 
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localization in uninfected cells.  When the Group I and Group II SM-GFP fusion 
proteins were expressed in infected cells, there was no detectable difference in 
the localization patterns between the Group I and Group II proteins.  These data 
suggest that altering the distance to the first charged a.a. did not alter the ability 
of the SM to direct the GFP fusion proteins to the nucleus.  The Group III and 
Group IV fusion proteins were detected mostly in the cytoplasmic membranes, 
suggesting that altering the length and/or the chemical character of the TM 
sequence of the SM did alter the ability of the SM to direct proteins to the 
nucleus.   Combined, these results suggest that during infection the 
characteristics of the TM sequence of the SM may be the most important feature 
of the SM. 
The role of the charged a.a. within the E66 SM 
 To further characterize the role of the charged a.a. within the E66 SM, a 
series of mutations were designed to mutate one or more of the charged a.a. of 
the SM in full length ODV-E66 (Fig. 24).  These mutations changed the selected 
charged residue(s) to: 1) Alanine; 2) A different a.a. with the same net charge 
(i.e. K to R); or 3) An a.a. with an opposite net charge (i.e. K to D or D to K).  
These mutated ODV-E66 sequences were cloned into pIE1 for expression in 
uninfected Sf9 cells.  These experiments were designed such that the 
differences in the localization of the mutated ODV-E66 would be determined by 
light confocal microscopy using ODV-E66 antibodies (Ab).  In the initial 
experiments, the E66 Ab could not detect the mutated E66 by confocal 
91 
 
Figure 24  Sorting motif charge mutations within ODV-E66.  Mutations of the protein 
sequence within the SM’s cluster of charged a.a. constructed within ODV-E66.  Altered a.a. are 
noted in bold. 
 
microscopy.  Furthermore, wild type E66, expressed as a control, was also not 
detected (data not shown).  This indicated that insufficient levels of E66 were 
produced in transfected cells.  Previous studies of a viral protein, FP25K, 
showed that when the FP25K gene is deleted from the viral genome, the 
translation of E66 during infection is significantly decreased (118) suggesting 
FP25K may regulate translation of E66.  In an effort to boost the translation 
levels of the E66 in transfected cells, FP25K and the wild type or the mutated 
E66 were co-transfected into Sf9 cells.  FP25K was detected in these cells, 
however E66 was still not expressed at detectable levels (data not shown).  
These results suggest that even though the IE1 promoter is recognized and 
utilized by the cellular machinery in uninfected cells, E66 translation is possibly 
regulated by unknown factor(s) during viral infection.  As a consequence, these 
studies could not be completed.   
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Another approach to determine where proteins containing mutations 
within the charged a.a. of the SM were sorted was attempted.  DNA constructs 
which coded the first 125 a.a. of E66 (with and without the mutations) fused to 
GFP were generated (Fig. 25) and expressed transiently in Sf9 cells.  When 
these constructs were transfected into Sf9 cells, the GFP fusion proteins were 
not expressed at detectable levels (data not shown).  Since GFP fusion proteins 
containing the first 33 a.a. of E66 were expressed at detectable and the GFP 
fusion proteins containing the first 125 a.a. of E66 were not, it is likely that the 
a.a. sequence between residues 33 and 125 is important for regulating E66 
translation.  Since these studies were designed to investigate the role SM 
charged a.a. in sorting and localization to the INM, the lack of expression in 
uninfected cells prohibited these studies from being completed.  The studies  
 
 
 
Figure 25.  Charge mutated E66-GFP fusion proteins.  Modifications of the protein sequence 
within SM charged cluster of a.a. constructed within GFP fusion proteins of the first 125 a.a. 
ODV-E66.  Altered a.a. are noted in bold. 
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using the first 33 a.a. of the SM indicated that the spacing between the TM and 
the charge a.a. was an important feature of the SM for sorting to the NE in 
uninfected cells.  Further characterization of the charged a.a. was not pursued. 
The essential features of the E66 SM are conserved in the cellular INM 
protein, lamin B receptor 
The N-terminal 238 a.a. of LBR are sufficient for localization and 
accumulation of a GFP fusion  (1-238LBR-GFP) to the INM and/or nuclear 
envelope (NE) of mammalian (199) and plant (219) cells.  This region of LBR 
(Fig. 26) encodes a N-terminal, 200 a.a. nuclear ligand-binding sequence and 
the first TM sequence.  The nuclear ligand-binding sequence binds lamin B (205, 
206), DNA (206), chromatin (207), and the chromatin binding protein, HP1 (208).  
Binding of these immobilized nucleoplasmic components is believed to be 
responsible for the sorting and retention of LBR in the INM.  In addition to the 
nuclear ligand-binding sequence, the N-terminal 238 a.a. of LBR also contains a 
SM-like sequence (a.a. 200-238) with chemical characteristics similar to the E66 
 
 
Figure 26.  Amino terminal 238 a.a. of lamin B receptor. 
 
SM (Fig. 26; Braunagel et al. (119) for review).  Since the SM features are 
apparently conserved in LBR, a study was done comparing the sorting and 
localization of the E66 SM-GFP fusion with the 1-238LBR-GFP fusion.  To 
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determine if the SM-like region of LBR could sort proteins to the INM in the 
absence of the retention domain, two additional LBR-GFP fusions were included 
in the comparison: 200-238LBR-GFP lacked the nuclear ligand-binding sequence, 
and 208-238LBR-GFP lacked the binding sequence and the nucleoplasmic 
charged a.a. of LBR (Fig. 27).   
 
 
 
Figure 27.  LBR-fusion proteins used for orientation studies.  Schematic of the LBR protein 
sequences and fusions used in the in vitro glycosylation assays. 
 
Orientation of the LBR-fusion proteins.  Immobilization and retention of LBR 
via binding to nucleoplasmic components requires that the LBR nuclear ligand-
binding sequence be oriented within the nucleoplasm.  Since the subsequent 
experiments were designed to compare the sorting in both insect and 
mammalian cells, orientation of the LBR GFP fusion proteins was tested to 
determine if these proteins had the same orientation in each cell type.   
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Figure 28.  Autoradiographs of SDS-PAGE gels from the orientation studies. A.) 
Glycosylation assay results from experiments conducted in canine derived microsomal 
membranes. B.) Glycosylation assay results from experiments conducted in Sf9 derived 
microsomal membranes.  Dots represent glycosylated protein. 
 
Orientation was determined using an in vitro glycosylation assay (321, 
322).  Briefly, mRNAs encoding LBR-fusion proteins with either an engineered 
amino- or carboxy-terminal consensus glycosylation acceptor sequence, NST, 
(Fig. 27) were translated, in vitro, with or without microsomal membranes.  
Following translation, one membrane reaction was treated with endoglycosidase 
H. The translated proteins were analyzed by SDS-PAGE and autoradiography.  
These experiments were performed using microsomal membranes derived from 
either canine pancreas or Sf9 cells. 
When the NST sequence was placed at the amino terminus of 1-238LBR-
GFP (Fig. 27; #1), no change in relative mobility (Mr) was observed (Fig. 28A; 
lanes 1-3).  However, when the NST was placed at the carboxy terminus of 1-
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238LBR (Fig. 27; #1), a band with a higher Mr was detected, consistent with 
glycosylation was observed (Fig. 28A; lanes 4-6).  Treatment with 
endoglycosidase H reversed the shift, indicating the higher Mr form was due to 
the addition of high mannose type oligosaccharides .  These data indicate the 
amino terminus of 1-238LBR-GFP is oriented on the cytoplasmic side of the 
microsomal membranes.  An endoglycosidase H sensitive band was observed 
when either 200-238LBR-GFP or 208-238LBR-GFP, with an amino-terminal NST, 
were assayed (Fig. 28A, lanes 7-12). Thus, the orientation of 200-238LBR-GFP 
and 208-238LBR-GFP is opposite of the 1-238LBR-GFP; the amino terminus of both 
fusion proteins is oriented on the lumenal side of the microsomal membranes, 
the same orientation as reported for the E66 SM (119).  Orientation assays 
using microsomal membranes derived from Sf9 cells showed the same results 
as the canine derived membranes (Fig. 28B).  Protease protection assays  
 
 
 
Figure 29.  Orientation of LBR- and SM-fusion proteins.  Orientation as predicted by the site-
directed glycosylation and protease protection assays. 
 
97 
confirmed the results of the glycosylation experiments (data not shown).  These 
studies showed that the amino terminal 208 a.a. of LBR are oriented in the 
cytoplasm (nucleoplasm) in both mammalian and insect cell membranes (Fig. 
29).  When the amino terminal 200 a.a. of LBR was removed, the first TM 
sequence of LBR adopted the opposite orientation (Fig. 29). This result suggests 
that the determinants for the orientation of the first TM sequence of LBR may be 
within the first 200 a.a. of LBR. 
Localization of LBR- and SM-GFP fusion proteins in mammalian and insect 
cells. Studies of several cellular INM proteins suggest accumulation in the INM 
requires a nucleoplasmic binding sequence to immobilize or reduce the mobility 
of the protein via binding to immobilized nuclear ligands or other resident INM 
proteins (198-200, 231).  However, these cellular INM proteins also contain 
sequences similar to the E66 SM (119). To investigate whether the SM or SM-
like sequences are sufficient for accumulation of LBR in the INM, three LBR-
fusion proteins and the E66 SM-GFP (Fig. 30) were expressed in CHO-K1 and 
uninfected Sf9 cells.   
 
 
Figure 30.  LBR- and SM-GFP fusion proteins used in CHO and Sf9 expression studies. 
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Figure 31.  Confocal microscopy images of the GFP-fusion proteins expressed in CHO-K1 
cells.  Rows A-D are defined by the fusion proteins A-D in Figure 30.  Each image represents a 
single z axis section through the center of the nucleus. Calnexin (red) and mAb414 (white) 
antibodies were used to label the ER and nuclear pores respectively.  The auto-fluorescence of 
the GFP fusion is shown as green. The merge column shows the three labels overlaid with the 
nuclear pores re-colored as blue. 
 
When expressed in CHO-K1 cells, 1-238LBR-GFP showed a pronounced 
nuclear rim of fluorescence (Fig. 31A).  This pattern is consistent with the results 
observed by Ellenberg et al. (199).  When expressed in Sf9 cells, the 1-238LBR-
GFP showed a prominent rim of fluorescence around the nucleus as well as 
being detected within cytoplasmic membranes (Fig. 32A). 
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Figure 32.  Confocal microscopy images of the GFP-fusion proteins expressed in 
uninfected Sf9 cells.  Rows A-D are defined by the fusion proteins A-D in Figure 30.  Calnexin 
(red) and Adl67 (white) antibodies were used to label the ER and nuclear lamin respectively.  
The auto-fluorescence of the GFP fusion is shown as green. The merge column represents the 
three images overlaid with the lamin re-colored as blue. 
 
To determine if the SM-like region of LBR was sufficient to direct GFP 
fusions to the INM, two additional LBR fusion proteins, 200-238LBR-GFP and 208-
238LBR-GFP (Fig. 30), were constructed and expressed in both CHO-K1 and 
SF9 cells.  The 200-238LBR-GFP lacks the nucleoplasmic 200 a.a. nuclear ligand-
binding sequence of LBR, and 208-238LBR-GFP lacks both the binding sequence 
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as well as the charged a.a. on the amino terminal side of the TM sequence.  
When expressed in CHO-K1 cells, 200-238LBR-GFP or 208-238LBR-GFP (Fig. 31B, 
31C), showed: 1) significant localization and accumulation in a subset of ER 
membranes juxtaposed to the NE; 2) distinct nuclear rimming; and 3) diffuse 
localization throughout ER membranes.   When expressed in Sf9 cells (Fig 32B, 
32C), the two LBR-fusions showed a pronounced rim of fluorescence around the 
nucleus as well as localization throughout the ER membranes (co-localization 
with calnexin).  The prominent rim of fluorescence around the nucleus exhibited 
by these two LBR-fusions expressed in uninfected Sf9 cells suggests that 
accumulation in the NE does not require a nuclear ligand-binding sequence and 
that the SM-like sequence of LBR is sufficient to concentrate membrane proteins 
in the NE, with a pattern similar to the E66 SM. 
The E66 SM-GFP lacks identifiable sequences that bind immobilized 
nuclear ligands.  When expressed in CHO-K1 cells (Fig. 31D), the SM-GFP 
localization pattern was indistinguishable from the 200-238LBR- and  
208-238LBR-GFP fusions.  In Sf9 cells (Fig. 32D), SM-GFP exhibited a 
pronounced nuclear rim of fluorescence as well as fluorescence in cytoplasmic 
membranes.   
The results of 200-238LBR-GFP, 208-238LBR-GFP and SM-GFP expression 
and localization in CHO-K1 and Sf9 cells show that SM or SM-like sequences 
are sufficient for membrane protein accumulation in or around the NE (as 
determined by an observed pronounced nuclear rim of fluorescence) in both 
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mammalian and insect cells.  However, when 1-238LBR-GFP was expressed in 
either CHO-K1 or Sf9 cells, a larger proportion of the total protein is apparently 
localized in NE, suggesting that the LBR nuclear ligand-binding sequence may 
contribute to the relative amount of protein accumulating in the NE.   
Nuclear envelope proteins and viral envelope proteins are sorted 
separately at the INM during viral infection.  Recombinant viruses expressing 
the LBR-GFP and SM-GFP (Fig. 30) fusions under the AcMNPV polyhedrin 
promoter were used to investigate whether LBR-GFP fusion proteins containing 
SM-like sequences are sorted differently from the E66 SM fusion during 
infection.  Localization of the GFP fusion was determined using light confocal 
microscopy at 48 (Fig. 33) and 72 h p.i (data not shown).  As reported, the E66 
SM-GFP fusion (Fig 30D) co-localized with the viral envelope protein E66, 
showing this fusion accumulates in the viral-induced intranuclear microvesicles 
(Fig. 33D) and ODV envelopes (data not shown) during infection (119, 152).  
The three LBR-GFP fusion proteins (Fig. 30A, 30B, 30C) were detected in both 
the NE and ER membranes during infection (Fig. 33A, 33B, 33C), although a 
minimal amount of 1-238LBR-GFP was also detected in the nucleus of infected 
cells.  These data suggest two possibilities: 1) sorting events induced by 
infection distinguish the E66 SM sequence from the cellular SM-like sequences 
in the INM, effectively excluding the cellular SM sequences from sorting to viral 
induced microvesicles and viral envelopes; or 2) the LBR fusions are 
immobilized at the INM. 
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Figure 33.  Confocal microscopy images of the GFP-fusion proteins expressed in infected 
Sf9 cells.  The fusion proteins in rows A-D (defined by the fusion proteins A-D in Figure 30) 
were expressed during infection under the polyhedrin promoter.  Infected cells were imaged 
confocally at 48 h p.i. and a representative z-axis section from the center of the nucleus shown.  
Adl67 (red) anti-bodies and E66 (white) were used to label the nuclear lamin and the ODV-E66, 
respectively.  GFP auto-fluorescence is represented as green. The merge column represents the 
three images overlaid, with E66 re-colored as blue.   
 
Localization of proteins to the INM does not require nuclear ligand-binding 
sequences 
While nuclear rimming is considered indicative of protein localization in 
the NE, it may not necessarily specify if the protein is in the outer, inner, or both 
membranes of the NE.  By immunoelectron microscopy, Ellenberg et al. (199) 
shows that the nuclear rimming of 1-238LBR-GFP expressed in COS-7 cells 
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represents protein localization in the INM.  Several studies use a digitonin 
permeabilization assay combined with antibody accessibility/detection to 
determine that a pronounced nuclear rim of fluorescence represents localization 
of a specific integral membrane protein in the INM [Emerin: Ostlund et al. (200); 
MANI: Wu et al. (231); Lap I, Maison et al. (220)].  When used at low 
concentrations, digitonin selectively permeabilizes the plasma membrane 
without permeabilizing the NE.  Therefore, in digitonin permeabilized cells, 
antibodies will only have access to epitopes that are extracellular or exposed 
within the cytoplasm (319).  Thus, protein localization in the INM can be 
determined by comparing confocal immuno-localization patterns of digitonin 
permeabilized cells to either auto-fluorescence patterns in the same cell, or 
immuno-localization patterns in Triton X-100 permeabilized cells. 
Cellular markers were used as internal controls to determine verify the 
validity of the digitonin permeabilization assay.  In CHO-K1 cells, antibody to 
calreticulin was used as a marker for the ER lumen.  Antibody to the cytoplasmic 
segment of calnexin, an integral membrane protein of the ER, will have equal 
access to the epitope in digitonin and Triton X-100 permeabilized cells.  As 
expected, in digitonin permeabilized CHO-K1 cells, calreticulin was not detected 
(Fig. 34A1a); whereas, calreticulin was detected in TX-100 permeabilized cells 
(Fig. 34A2a).  Calnexin was detected in CHO-K1 cells permeabilized with either 
digitonin or Triton X-100 (Fig. 34A1b, 34A2b).  In Sf9 cells, antibody (Adl67) to 
the insect lamin, Dm0, were used as a marker for the nucleoplasmic lamina.  In 
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digitonin permeabilized cells the nuclear envelope is intact, and the lamin 
epitopes are not accessible to antibody, however in Triton X-100 permeabilized 
cells the nuclear envelope is permeabilized, and therefore the antibody will have 
access to the lamin epitope.  Antibody to the cytoplasmic segment of calnexin 
(ER) was also used in Sf9 cells.  In digitonin permeabilized Sf9 cells, Adl67 did 
not detect the insect lamina (Fig. 34B1), but did detect the lamina in Triton X-100 
permeabilized Sf9 cells (Fig. 34B2).  Antibody to calnexin detected the protein in 
the ER of both digitonin and Triton X-100 permeabilized Sf9 cells. These data 
verified that the conditions used for digitonin permeabilization in both CHO-K1 
and Sf9 cells were suitable. 
The N-terminus of 1-238LBR-GFP is exposed to the cytoplasm, placing 
GFP in the lumen of the ER/NE (Fig. 28).  Therefore the GFP is not accessible 
to antibodies in digitonin permeabilized cells.  To detect 1-238LBR-GFP, a T7 
epitope tag was engineered at the N-terminus of 1-238LBR GFP (Fig. 34C).  In 
digitonin permeabilized CHO-K1 cells, T71-238LBR-GFP was not detected by the 
T7 Ab when expressed at average levels (Fig. 34A1a).  However, GFP auto-
fluorescence showed a pronounced rim around the nucleus.  T71-238LBR-GFP 
was detected with T7 Ab in the ER of CHO-K1 cells that expressed high levels of 
the GFP fusion (Fig. 34A1b).  The GFP autofluorescence showed a pronounced 
rim of fluorescence around the nucleus and detected the T71-238LBR-GFP  
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Figure 34.  Digitonin permeabilization of cells CHO-K1 or Sf9 cells expressing  
1-238LBR-GFP.  (A) The T71-238LBR-GFP fusion expressed in CHO-K1 cells.  Digitonin or Triton 
X-100 permeabilized cells were imaged confocally with a representative z-axis section from the 
center of the nucleus shown.  T7 (red) anti-bodies were used to label the fusion protein and 
calreticulin (white, top panel) or calnexin (white, bottom panel) antibodies were used to label the 
ER.  GFP auto-fluorescence is shown as green. The merge column shows the three images 
overlaid with calreticulin or calnexin re-colored as blue. Cells expressing low levels of 1-238LBR-
GFP are shown in row (a). Cells expressing high levels of 1-238LBR-GFP are shown in (b).  (B) 
The 1-238LBR-GFP fusion expressed uninfected in Sf9 cells, permeabilized and imaged as in 
panel A.  Adl67 (white, top panel) or calnexin (white, bottom panel) antibodies were used to label 
the lamin or ER, respectively. The merge column shows the three labels overlaid with Adl67 or 
Calnexin re-colored as blue. (C) Schematic drawing of the T71-238LBR-GFP fusion. 
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protein in the ER, when expressed at high levels.  Conversely, in Triton X-100 
permeabilized CHO-K1 cells, the T7 Ab co-localized with the GFP 
autofluorescence (Fig. 34A2a, 34A2b) in the nuclear rim and in the ER.  
Therefore, consistent with the published data (199), the pronounced nuclear rim 
of 1-238LBR-GFP represented protein accumulation in the INM of CHO-K1 cells.   
In digitonin permeabilized Sf9 cells expressing T71-238LBR-GFP, the T7 Ab only 
detected fusion protein in the ER (Fig. 34B1).  The GFP auto-fluorescence 
showed this LBR-fusion accumulating with a pronounced rim of fluorescence 
around the nucleus and accumulating in the ER (Fig. 34B2).  In Triton X-100 
permeabilized Sf9 cells, both the T7 Ab and the GFP auto-fluorescence showed 
T71-238LBR-GFP accumulating with both a fluorescent nuclear rim pattern and in 
the ER.  Therefore, in Sf9 cells, the results from transient expression studies 
demonstrated that the nuclear rimming observed for 1-238LBR-GFP represented 
accumulation in the INM.   
SM-GFP orientation studies (119) determined the GFP is oriented toward 
the cytoplasm/nucleoplasm.  Therefore, in the permeabilization assay, GFP 
antibody was used to detect the SM-GFP.  In digitonin permeabilized Sf9 cells, 
GFP antibody detected SM-GFP in the ER, whereas the auto-fluorescence 
showed the both a fluorescent nuclear rim and fluorescence in the ER (Fig. 
35A1).  In Triton X-100 permeabilized Sf9 cells, the GFP antibody and GFP 
auto-fluorescence showed the SM-GFP fluorescence in the ER and rimming the 
nucleus (Fig. 35A2).  These patterns of fluorescence localization showed that  
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Figure 35.  Digitonin permeabilization of CHO-K1 and Sf9 cells expressing the SM-GFP.  
The SM-GFP fusion expressed in: A.) Sf9 cells or B.) CHO-K1 cells. 1.) Digitonin or 2.) Triton X-
100 permeabilized cells were imaged confocally with a representative z-axis section from the 
center of the nucleus shown.  GFP (red) anti-bodies were used to label the fusion protein and 
calnexin (white) antibodies were used to label the ER.  GFP auto-fluorescence is shown as 
green. The merge column shows the three images overlaid with calreticulin or calnexin re-
colored as blue. 
 
the SM-GFP pronounced nuclear rim of fluorescence represented protein 
accumulation in the INM of Sf9 cells.  When expressed in CHO-K1 cells, SM-
GFP was detected mostly in regions juxtaposed to the NE, however, a 
fluorescent nuclear rim was also observed.  When CHO-K1 cells were 
permeabilized with digitonin, GFP antibody detected the protein in the ER 
membranes juxtaposed to the NE (Fig. 35B1).  While in the digitonin 
permeabilized CHO-K1 cells there may be a minor portion of the SM-GFP in the 
nuclear rim that was not detected with the GFP antibody, the results were not 
able to demonstrate such localization. 
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Figure 36.  Digitonin permeabilization of CHO-K1 and Sf9 cells expressing the 200-238LBR- 
and 208-238LBR-GFP. The a.) 200-238LBR-GFP and b.) 208-238LBR-GFP fusions (Fig. 30) expressed 
in: A.) Sf9 cells or B.) CHO-K1 cells. 1.) Digitonin or 2.) Triton X-100 permeabilized cells were 
imaged confocally with a representative z-axis section from the center of the nucleus shown.  
GFP (red) anti-bodies were used to label the fusion protein and calnexin (white) antibodies were 
used to label the ER.  GFP auto-fluorescence is shown as green. The merge column shows the 
three images overlaid with calreticulin or calnexin re-colored as blue. 
 
Orientation studies showed that for 200-238LBR- and 208-238LBR-GFP fusion 
proteins, GFP is exposed to the cytoplasm.  Therefore, GFP antibodies were 
used to detect these fusion proteins.  In digitonin permeabilized Sf9 cells, the 
GFP antibody detected 200-238LBR- and 208-238LBR-GFP colocalized with the ER 
marker protein, calnexin.  The GFP autofluorescence demonstrated a 
fluorescent nuclear rim and fluorescence in the ER (Fig. 36A1).  In Triton X-100 
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permeabilized Sf9 cells, the GFP antibody and autofluorescence showed the 
fusion proteins in both the nuclear rim and the ER.  These data suggest that the 
fluorescent nuclear rimming observed for these two fusion proteins represents 
protein accumulation in the INM of SF9 cells.  When CHO-K1 cells expressing 
either LBR-fusion were permeabilized with digitonin, antibody to GFP detected 
the fusion proteins in the ER membrane juxtaposed to the NE (Fig. 36B1).  
Again, while there may have been some portion of the GFP fusions in the 
nuclear rim that was not detected with the GFP antibodies, the results from 
these two LBR-GFP fusions were not able to demonstrate such localization. 
The results from the digitonin permeabilization studies of CHO-K1 cells 
expressing the SM-GFP, 200-238LBR- and 208-238LBR-GFP fusion were not able to 
demonstrate distinct localization in the INM.  However, when these fusions were 
tested using digitonin permeabilization in Sf9 cells, the data clearly showed that 
these fusion proteins concentrate in the INM.  Therefore, the Sf9 data suggests 
that protein accumulation in the INM is not necessarily dependent on the 
presence of a nuclear ligand-binding sequence and is likely mediated, in part, by 
SM or SM-like sequences.  
Accumulation of proteins in the INM can be independent of immobilization
 FRAP studies of four INM proteins show that the population of INM 
protein in the ER is mobile, while that population of protein in the INM is either 
immobile, or has significantly decreased mobility [Emerin: Ostlund et  
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al. (200), LBR: Ellenberg et al. (199), MANI: Wu et al. (231), and Nurim: Rolls et 
al. (198)].  The LBR- and SM-GFP fusions in this study accumulate in the INM 
when expressed in uninfected SF9 cells.  Of these four fusion proteins, only the 
1-238LBR-GFP convincingly accumulates in the INM of CHO-K1 cells.  However 
Sf9 digitonin permeabilization studies of LBR-fusions lacking a nuclear ligand-
binding sequence, as well as the SM-GFP, suggest that immobilization via direct 
binding of nucleoplasmic components is not necessary for sorting and 
accumulation of all INM proteins to the INM.  However, one could argue that 
these proteins may be immobilized in the INM via interactions in the TM 
sequence.  FRAP was used to determine if there were differences in the mobility 
of the LBR- or SM-GFP in the ER and the INM/NE when expressed in CHO-K1 
or uninfected Sf9 cells.  When 1-238LBR- GFP was expressed in the mammalian 
cell line, CHO-K1, results consistent with previous reports were obtained (199); 
the fusion was immobile in the INM and mobile in the ER (recovery profile: Fig. 
37A; diffusion constant: Fig. 37C; CHO-K1).  However, when 1-238LBR-GFP was 
expressed in Sf9 cells the ER and NE populations of this fusion protein were 
mobile and had similar recovery profiles (Fig 37B). There was no significant 
difference in the calculated diffusion constants (Fig 37C; Sf9).  The 200-238LBR-
GFP, 208-238LBR-GFP and the viral SM-GFP accumulated in the INM when 
expressed in uninfected SF9 cells, and in the ER membranes juxtaposed to the 
NE in CHO-K1 cells.  For these proteins, FRAP studies determined that there  
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Figure 37.  Fluorescence recovery after photo bleaching.  (A) A representative recovery 
profile of 1-238LBR-GFP expressed in the ER and INM of CHO-K1 cells.  (B) Representative 
recovery profile of 1-238LBR-GFP expressed in the ER and INM of Sf9 cells.  (C) Diffusion 
constants (D, µm2/s) for the LBR and SM-GFP fusions in the ER and NE/INM of mammalian and 
insect cells.  The fusion proteins were considered mobile if greater than 35% of the fluorescence 
recovered following photo-bleaching (4 minutes).  Simple t-test (95% confidence interval) for the 
remaining assays showed the differences in D values in the NE and ER were not significant.  
Results are mean +/- std. error for (n) determinations. 
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was no significant difference in the calculated diffusion constants between the 
ER and NE/INM populations (Fig. 37C) of either CHO-K1 or Sf9 cells.  
Combined, the digitonin permeabilization and FRAP data obtained from SF9 
cells suggest that sorting and accumulation of proteins to the INM can be 
independent of immobilization. 
The pathway of trafficking proteins to nuclear membranes may be 
saturated during infection 
When the LBR- or SM-GFP fusion proteins were abundantly expressed 
during infection, an unexpected result was noted; in cells expressing high 
amounts of E66, a proportion of E66 was detected in cytoplasmic membranes 
(Fig. 38).  This result suggested that trafficking of E66 to the viral induced 
intranuclear membranes was delayed.  One possible explanation for the delay in 
E66 trafficking is that the abundant SM or SM-like sequences were saturating 
unidentified factor(s) required for trafficking to nuclear membranes.  
To determine if the observed qualitative differences in the localization of 
E66 were significant, the relative amounts of E66 and the SM-GFP or 1-238LBR-
GFP in the cytoplasm, nuclear envelope, and intranuclear microvesicles were 
quantified and compared in wild type virus and recombinant viruses expressing 
either 1-238LBR-GFP or SM-GFP.  A macro was written for the KS400 software 
package that allowed for quantitation of the amount of label localized in each 
cellular locale (Fig. 39D) as well as the area for each locale.  For each label  
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Figure 38.  Representative confocal microscopy images from infected cells used in the 
quantitation assays. Representative images of confocal microscopy from infected cells (48 h 
pi.) of both wild type and recombinant viruses expressing high levels of ODV-E66.  E66 (red) 
anti-bodies and Lamin (blue) were used to label the ODV-E66 and the nuclear lamin, 
respectively.  GFP auto-fluorescence is represented as green. The merge column represents the 
three images overlaid.   
 
quantified, a density ratio was calculated (% label/%area).  The density ratios 
were normalized to 100%, and plotted on histograms.   
Calnexin and Lamin were used as cellular controls.  For calnexin, the 
histogram (Fig. 39A) showed that the majority of the label was detected within 
the cytoplasm of the infected cells.  The histogram (Fig. 39A) for lamin shows 
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Figure 39.  Histogram representation of quantified labels from each cellular compartment.   
A.) Histogram showing the density ratio of calnexin and lamin localization in each cellular 
compartment of wt infected cells (n=10).  B.) Histogram showing the density ratio of SM-GFP or 
1-238LBR-GFP localization in each cellular compartment of cells infected with the SM-GFP (n=7) 
or 1-238LBR-GFP (n=10) recombinant viruses.  C.) Histogram showing the density ratio of E66 
localization in each cellular compartment of cells infected with the WT (n=10), SM-GFP (n=7) or 
1-238LBR-GFP (n=10) recombinant viruses.  Histogram error bars represent standard deviation.  
D.) Pictorial representation of the three cellular compartments defined by the macro used for 
quantitation. 
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that the majority of the label is detected within the nuclear rim.  This data is 
consistent with the expected and observed localization (data not shown) of each 
of these proteins.  For the SM-GFP, the histogram (Fig. 39B) shows the majority 
of the label was localized within the nucleus.  This localization is consistent with 
the microscopy data shown in Fig. 38.  For the 1-238LBR-GFP, the histogram data 
showed the majority of the label was localized within the nuclear rim (Fig. 39B).  
Again, this is consistent with the observed localization shown on Fig. 38.    
For the wt, SM-GFP, and 1-238LBR-GFP, the histogram (Fig. 39C) shows 
that the majority of the E66 label is localized within the nucleus.  While an 
increase in the amount of E66 localization within the cytoplasm of cells infected 
with either the SM-GFP or 1-238LBR-GFP recombinant viruses were visually 
apparent (Fig. 38), the histogram of the quantified E66 localization in each locale 
showed these visual differences are either not significant or not quantifiable 
using the available software and/or macro.  However, the histogram data does 
suggest a trend that indicates the amount of E66 excluded from the viral-induced 
intranuclear microvesicles increases as of amount of protein with SM or SM-like 
sequences in transit to nuclear membranes increases.  This data suggests that 
the protein trafficking pathway to nuclear membranes may be a saturable 
process. 
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DISCUSSION 
 
SM or SM-like sequences can mediate the sorting of integral membrane 
proteins to the INM independent of immobilization 
The N-terminal 33 a.a. E66 sorting motif (SM) (Fig. 23) is sufficient to sort 
β-galactosidase and GFP fusion proteins to MV and ODV envelopes during 
infection.  When abundantly expressed during infection, the SM-fusion proteins 
can also be detected in the INM, ONM and ER.  These data suggest that SM-
fusion proteins sort to the INM, MV and ODV envelopes using a trafficking 
pathway similar to that of resident INM proteins (152).   
To investigate the essential features of the SM, selected mutations that 
removed or altered one or more of the predicted essential features of the SM 
were generated (Fig. 13).  These mutant SM sequences were fused to GFP and 
expressed in both uninfected and infected Sf9 cells.  The localization and 
membrane association of each mutant SM fusion was determined.  Each of the 
mutant SM-GFP fusion proteins were classified into one of four groups based on 
their localization patterns when expressed in uninfected cells.   
The Group I fusion proteins colocalized with the ER marker protein, 
calreticulin, formed a pronounced rim of fluorescence around the nucleus (Fig. 
14) and fractionated as integral membrane proteins (Fig. 18).  The mutations to 
the SM fusion proteins classified in this group included: 1. replacing the aromatic 
a.a. with leucine; 2. replacing the cysteine with leucine; 3. removing the polar 
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a.a. between the end of the TM sequence and the first charged a.a.  In each 
case the distance between the end of the TM sequence and a positively charged 
a.a. remained five residues.  The results from the Group I SM-fusion proteins 
suggest that the cysteine and the aromatic amino acids located within the TM 
sequence are not required for sorting of the SM to the NE of uninfected cells. 
The mutations within the Group II SM-GFP fusion proteins all resulted in 
an increase between the end of the TM sequence and the first charged a.a. to 6 
or more residues. Furthermore, the mutations in two of these fusion proteins 
(SM3B, SM3D) resulted in changing the first charged a.a. from a lysine to a 
glutamic acid.  When expressed in uninfected cells, these mutant SM-GFP 
fusion proteins were also detected colocalizing with calreticulin and forming a 
pronounced rim nucleus (Fig. 15).  However, the relative ratio of the protein 
localizing in the nuclear rim vs. the ER membranes decreased; the Group II 
fusion proteins did not form as strong of a nuclear rim as those in Group I.  The 
Group II fusion proteins also fractionated as integral membrane proteins (Fig. 
18).  This data suggests that the distance between the end of the TM sequence 
and the first positively charged a.a. is important for sorting the SM to the NE.  
The mutations in the Group III SM-GFP fusion proteins likely resulted in: 
1. an increase in the length of the TM sequence from ~18 a.a. to ~34 a.a.; 2. 
shortening the distance from the end of the TM sequence to less than five a.a.; 
and 3. changing the first charged a.a. following the TM sequence from a lysine 
to a glutamic acid.  When these mutant fusion proteins were expressed in 
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uninfected cells, they were detected in the cytoplasmic membranes or the PM 
(Fig. 16) and were secreted (Fig. 18).   
The mutations in the Group IV SM-GFP fusion proteins resulted in: 1. 
introducing polar a.a. into the TM sequence; and 2. shortening the distance 
between the end of the TM sequence and the first positively charged a.a.  When 
these fusion proteins were expressed in uninfected cells, the protein(s) 
accumulated in the ER, but did not concentrate in the NE (Fig. 17).  
Furthermore, fractionation studies showed that these fusion proteins did not 
fractionate as integral membrane proteins (Fig. 18).  This data suggests that 
when the SM is only peripherally associated with the membranes, it is not sorted 
to the NE. 
Therefore, the mutational analysis defined the following characteristics as 
essential features of the SM: 1. an integral membrane protein; 2. a TM sequence 
lacking polar or charged a.a.; and 3. a positively charged a.a. spaced 5 residues 
from the end of the TM sequence (Fig. 19).  When these essential features of 
the SM are compared to sequences required for correct localization of either 
cellular INM or nuclear pore membrane proteins, the features are conserved 
(119).   
When the E66 SM-GFP fusion protein (SM1A) was expressed during 
infection, the protein was detected in the viral induced intranuclear membranes 
(Fig. 20) with a pattern similar to that seen for ODV-E66 in cells infected with wt 
virus.  When the Group I and II fusions were expressed in infected cells, the 
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patterns of localization all resembled that seen for the E66 SM-GFP fusion.  This 
suggests that a 5 residue spacing between the end of the TM and the first 
positively charged amino acid is not essential in efficient sorting of the SM to the 
intranuclear membranes.  When the Group III fusion proteins were expressed in 
infected cells, the majority of the protein was detected in the cytoplasmic 
membranes, although, some protein was also detected in the nucleus (Fig. 22).  
The Groups I, II, and III fusion proteins fractionated as integral membrane 
proteins in infected cells (Fig. 18).  When the Group IV fusion proteins were 
expressed in infected cells, the proteins were detected in the cytoplasmic 
membranes surrounding the nucleus (Fig. 22), and fractionated as peripheral 
membrane proteins (Fig. 18).  Therefore, these data suggest that the minimum 
requirements for sorting the SM to viral induced membranes were different than 
that required for sorting to the NE of uninfected cells.  The nature of the 
differences in sorting the SM to the NE in the absence of infection vs. sorting to 
viral induced intranuclear membranes during infection was beyond the scope of 
this project.  
Studies to further investigate the role of the charged amino acids in 
sorting proteins to the INM and/or MV and ODV envelope were initiated.  These 
studies were designed to remove or change the chemical characteristics of the 
cluster of charged a.a. in E66.  However, several attempts to express the mutant 
E66 proteins (or the first 125 a.a. fused to GFP) in uninfected cells were 
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unsuccessful.  Further experiments to fully characterize the cluster of charged 
a.a. were not pursued. 
Braunagel et. al. (119) shows that the essential features of the E66 SM 
are conserved in several INM proteins.  To study the similarities and differences 
in the sorting of cellular INM proteins and the viral E66 SM to the NE, LBR was 
chosen as the protein for comparison.  This study used a previously 
characterized LBR-GFP fusion protein, 1-238LBR-GFP, that contains the 
determinants for sorting, localization and retention of LBR in the INM (196, 199).  
The N-terminal 238 a.a. of LBR include a N-terminal 200 a.a nuclear ligand-
binding sequence as well as a SM-like sequence (a.a. 200-238) with charged 
a.a. positioned on both sides of the TM sequence (Fig. 29).  Consistent with 
published data (199), this LBR fusion concentrated in the INM when expressed 
in CHO-K1 cells (Fig. 34A).  When 1-238LBR-GFP was expressed in uninfected 
Sf9 cells, the fusion protein also concentrated in the INM (Fig. 34B).   
Previous reports suggest that concentration of LBR in the INM requires 
binding to immobilized nucleoplasmic components via the nuclear ligand-binding 
sequence (199) and/or the first TM sequence plus flanking a.a. residues on 
either side of the TM sequence (196).  The first TM sequence of LBR, plus the 
flanking charged a.a. residues, have similar chemical characteristics to the a.a. 
sequence of the E66 SM (Fig. 6).  Two LBR-fusion proteins, 200-238LBR-GFP and 
208-238LBR-GFP were constructed and expressed to determine if the SM-like 
sequence of LBR was sufficient for sorting the fusion protein to the NE.  The 200-
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238LBR-GFP lacked the nuclear ligand-binding sequence of LBR, and 200-238LBR-
GFP lacked both the binding sequence and the charged a.a. on the N-terminal 
side of the TM.  These LBR-GFP fusions were similar to the E66 SM-GFP in 
both chemical characteristics (Fig. 24) and membrane orientation (Fig. 23).  
When 200-238LBR-GFP, 208-238LBR-GFP and SM-GFP were expressed in 
uninfected Sf9 cells, all three fusion proteins were detected in the ER and the 
INM (Fig. 35, 36).  However, when the fusion proteins expressed in CHO-K1 
cells, the data showed the proteins were detected in the ER and membranes 
juxtaposed to the nucleus, but could not determine if these fusion proteins 
accumulated in the INM.  However, the results from Sf9 cells are consistent with 
the hypothesis proposed in this study; accumulation of integral membrane 
proteins in the INM can be mediated by a SM or SM-like sequence. 
FRAP was used to determine if there were differences in protein mobility 
in the ER and NE/INM when the LBR- and SM-GFP fusions were expressed in 
either CHO-K1 or Sf9 cells.  When expressed in CHO-K1 cells, the 1-238LBR-
fusion protein was immobilized in the INM and mobile in the ER (Fig. 37).  This 
result was expected and is consistent with the reported results (199) and the 
diffusion:retention model.  However, when expressed in Sf9 cells, the 1-238LBR-
GFP INM and ER protein populations exhibited no significant difference in the 
calculated diffusion constant, which showed there was no decrease in mobility of 
1-238LBR-GFP in the INM.  This result was unexpected since the 1-238LBR-fusion 
localized in the INM of Sf9 cells and contains a binding sequence for the 
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immobilized nucleoplasmic components lamin B, DNA and/or chromatin (directly 
or indirectly).  The only insect lamin proteins identified to date are the Dm0 and 
Lamin C of Drosophila cells.  Drosophila Dm0 antibodies (Adl67) label the Sf9 
lamina (Fig. 31) suggesting the lamins of Drosophila may be similar to those in 
Sf9 cells.  While the Dm0 lamin is considered to be a lamin B equivalent based 
on expression profiles in their respective species, the two proteins are different 
in sequence (326, 327). Therefore, it is possible the lamin B binding sequence of 
LBR does not recognize insect lamin.  Despite the possible lack of lamin binding, 
it was surprising to find that this LBR fusion did not show at least a decreased 
mobility in the INM mediated by binding DNA and/or chromatin.  If LBR did bind 
either DNA or chromatin in Sf9 cells, this binding was not sufficient to decrease 
the mobility of the protein in the INM.  Mobility data from the two LBR fusions 
lacking the nuclear ligand-binding sequence, 200-238LBR-GFP and 208-238LBR-
GFP, and from the SM-GFP fusion showed that when expressed in either CHO-
K1 or uninfected Sf9 cells, these fusion proteins were mobile in both the NE/INM 
and the ER (Fig. 37).  If diffusion:retention is the only mechanism of INM protein 
sorting and accumulation, one would expect these fusion proteins to have either 
a decreased mobility or no accumulation in the INM of Sf9 cells.  However, the 
localization (Figs. 34-36) and FRAP data (Fig. 37) clearly show these proteins 
do concentrate in the INM of Sf9 cells, yet remain freely mobile.   
Given the localization and mobility of the LBR and E66 SM fusions and 
the data demonstrating that the altered orientation of the truncated LBR fusions 
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(Fig. 26) did not inhibit accumulation in the INM of Sf9 cells, the results 
presented in this study suggests that sorting and localization of integral 
membrane proteins to the INM can be mediated by a SM or SM-like sequence 
that functions either independent of, or in addition to, immobilization.   
Sorting of proteins to the INM can be a signal-mediated process regulated 
at various steps in the trafficking pathway 
Recent reports, combined with the results of this study, support a 
hypothesis that the sorting of proteins to the INM can be regulated at several 
steps throughout the protein trafficking pathway and can be independent of 
diffusion and immobilization.  The sorting and localization of membrane proteins 
to the INM can be regulated at 4 separate checkpoints: 1) co-translational 
integration in the ER (328); 2) trafficking through the ER and ONM to the nuclear 
pore (119); 3) trafficking from the ONM to the INM (118); and/or 4) sorting 
events within the INM that are independent of immobilization.   
Co-translational integration in the ER. Saksena et al. (323) demonstrate that 
sorting of INM proteins may begin as early as co-translational integration into the 
ER.  The authors report that viral (E66, E25) or cellular (LBR, Nurim) derived 
INM-directed TM sequences crosslink, in vitro, to the translocon proteins, 
Sec61α and TRAM.  Furthermore, the authors shows that the INM-directed TM 
sequences of the viral and cellular proteins are in similar protein environments 
based on the surfaces of the TM sequences which crosslinked to either Sec61α 
or TRAM.  The authors note that of the ten TM sequences tested, that are sorted 
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to sites other than the INM, only two crosslink to TRAM using photo-crosslinking 
methods.  Furthermore, of the seven non-INM directed TM sequences that have 
been studied at high resolution (using probes on several surfaces of the TM 
sequence), none show a crosslinking pattern similar to the four INM-directed TM 
sequences studied.  Therefore, based on the unique crosslinking pattern 
demonstrated by the viral and cellular INM-directed TM sequences, the authors 
propose that INM-directed TM sequences occupy a site in the translocon site 
that is unique when compared to TM sequences directed to other locations in 
the cell.  These data indicate that sorting of some viral envelope and INM 
proteins may begin during co-translational integration through the ER translocon.   
Trafficking through the ER and ONM to the nuclear pore. Published in vivo 
and in vitro protein crosslinking studies suggest that sorting of integral 
membrane proteins to the INM also may be regulated while the protein is 
trafficking through the ER/ONM to the INM.  Braunagel et al. (119) shows that an 
E66 SM fusion protein can crosslink two viral proteins, FP25K and E26, when 
the SM fusion is in the ER.  These data suggest that these viral proteins are 
proximal to SM in the ER and thus may be involved in facilitating the sorting of 
proteins with SM or SM-like sequences to the INM while the proteins are in the 
ER/ONM.  The specific function of these two viral proteins in the trafficking 
process requires more direct proof and is currently under investigation.  
Additionally, studies to identify potential cellular homologues of the viral proteins 
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are currently underway (Saksena, Ding and Braunagel, personal 
communication). 
Trafficking from the ONM to the INM.  Published reports suggest that diffusion 
of proteins from the ONM to the INM requires that the 
cytoplasmic/nucleoplasmic domain of a protein must be less than 50 kDa to 
pass through the 10 nm peripheral channels of the nuclear pore (185, 206).  
However, the Nesprin family of INM proteins have nucleoplasmic domains that 
are up to one MDa in size, yet these proteins are detected in the INM (204).  
ODV-E66 has a nucleoplasmic domain larger than 50 kDa (~63 kDa) but 
accumulates in the INM derived MV and ODV envelopes during infection.  
Rosas-Acosta et al. (118) reports that when FP25K is deleted from the AcMNPV 
viral genome, ODV-E66 is detected in clusters in the ONM and does not sort to 
MV and/or ODV envelopes.  These data suggest that FP25K may function, 
either directly or indirectly, to regulate the efficient transit of E66 from the ONM 
to the INM.  From these data, one could speculate a functional cellular homolog 
of FP25K may exist that regulates the trafficking of cellular INM proteins with 
large cytoplasmic/nucleoplasmic domains from the ONM to the INM.   
Viral induced sorting at the INM. Localization studies from infected cells 
demonstrate that sorting events at the INM distinguish viral SM sequences from 
cellular SM-like sequences (Fig. 33), actively excluding the cellular SM-like 
sequences from accumulating in viral-induced intranuclear MV and ODV-
envelopes.  By extrapolation from the studies in uninfected cells, proteins with 
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SM or SM-like sequences are predicted to be mobile in the INM of infected Sf9 
cells.  Therefore, the localization data from infected Sf9 cells suggests that 
sorting events at the INM may exist.   
Diffusion:retention may be sufficient to describe the sorting and 
localization of some integral membrane proteins to the INM.  However, the 
results from this study, combined with recently reported data (119, 323), suggest 
additional mechanisms.  These data predict that sorting and localization of 
integral membrane proteins to the INM can be mediated via protein sequences 
that contain the essential features identified in the SM of AcMNPV ODV-E66.  
Furthermore, this trafficking process can be a sequential and regulated multi-
step proteinaceous pathway that is independent of free diffusion and 
immobilization (119). 
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SUMMARY 
 
The diffusion:retention model of INM protein sorting and localization 
predicts that once a protein is integrated into the ER, it freely diffuses within the 
continuous membrane systems of the ER and NE.  Once the protein reaches the 
INM it binds nucleoplasmic components (via a nuclear ligand binding sequence) 
(195-197, 199) and/or other resident INM proteins (198) and becomes 
immobilized and thus retained in the INM.  This model infers that immobilization 
in the INM is the only known sorting event in INM protein trafficking.  However, 
recent studies using viral envelope proteins as markers to investigate the 
molecular basis and mechanisms involved in the pathway suggest sorting 
proteins to the INM is a regulated process that can be independent of 
immobilization. 
The amino terminal 33 a.a. of ODV-E66 (the sorting motif, SM) are 
sufficient for the localization of fusion proteins to viral-induced intranuclear 
microvesicles (MV) and ODV envelopes during infection (152).  When 
abundantly expressed, SM-fusions are also detected in the INM, ONM and ER, 
suggesting these SM-fusions use a trafficking pathway similar to that of resident 
INM proteins.  To investigate the essential features of the SM, mutational 
analyses were performed.  From these analyses, the essential features of the 
SM required for INM protein sorting and accumulation were determined to be a 
18 a.a. TM sequence that lacks polar and charged a.a. with a cluster of charged 
a.a. spaced 5-11 residues from the cyto-/nucleoplasmic side of the TM 
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sequence.   A comparison of the SM with known cellular INM proteins 
determined that the essential features of the SM were conserved. 
Notably, one feature absent from the SM that is present in most INM 
proteins (except nurim) is a nuclear ligand-binding sequence.  These binding 
sequences interact with immobilized nucleoplasmic components resulting in the 
immobilization of INM proteins in the INM, and therefore retention.  In this study 
the localization and mobility of the E66 SM was compared with the cellular INM 
protein lamin B receptor (LBR).  Three LBR fusion proteins (with and without the 
nuclear ligand-binding sequence) were expressed in mammalian and insect 
cells, and sorting similarities and differences were determined using light 
confocal microscopy and fluorescence recovery after photo-bleaching (FRAP).  
Lamin B Receptor is polytopic INM protein with an amino terminal, 200 a.a. 
nuclear ligand-binding sequence oriented within the nucleoplasm followed by 
eight TM segments.  The INM sorting signals for LBR are contained in the 
nuclear ligand-binding sequence (218) and/or “the first transmembrane region 
plus flanking residues on either side” (196).  The essential features of the E66 
SM are conserved within the region of LBR (a.a. 201-246) identified by Smith 
and Blobel, (196) as sufficient for LBR sorting to the INM.  The data from these 
studies suggests that localization of proteins to the INM does not require a 
nuclear ligand-binding sequence.  Furthermore, immobilization in the INM is not 
necessarily a prerequisite for concentration of integral membrane proteins in the 
INM. 
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The diffusion:retention model would predict that if the LBR-GFP fusions 
were not immobilized in the INM of insect cells, these proteins could accumulate 
in MV and ODV envelopes during infection.  However, localization studies show 
that while an ODV-envelope protein and the SM-GFP fusion partitioned to MV 
effectively during infection, the LBR-GFP fusion proteins did not.  Therefore, this 
data suggests that there are viral induced sorting events that can occur at the 
INM that are likely independent of immobilization. 
The results of this study, combined with recently reported data (119, 323) 
suggest that the sorting and localization of proteins to the INM can be directed 
by sequences which contain the essential features of the viral SM identified in 
this study.  Furthermore trafficking to the INM can be a sequential and regulated, 
multi-step, proteinaceous pathway independent of free diffusion and 
immobilization (119). 
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APPENDIX A 
 
Quantitation Macro 
 
#  This is a modified version of the TEXASAM.MCR macro. 
#5/12/2001 RSU 
#This macro allows the user to measure specific regions within an image. 
 
! imgsetpath "d:\" 
 
imgdelete "*" 
Gclear 0 
MBok "Place images into appropiate image channels: 1-Red, 5-Green, 6-Blue 
and 7-Brightfield" 
showwindow "Display",1 
showwindow "Gallery",1 
showwindow "Messages",1 
! MSload "basic"  
write "@" 
 
write "Load Red Channel" 
! imgload "d:\",1  
imgcopy 1,4 
 
write "Load Green Channel" 
! imgload "d:\",2  
imgcopy 2,5 
 
write "Load Blue Channel" 
! imgload "d:\",3 
imgcopy 3,6 
 
write "Load Brightfield Channel" 
! imgload "d:\",7  
imgdisplay 7 
 
write "Circle drawn around plasma membrane Part F." 
MBok  "Draw a circle around plasma membrane, Part F, at cutlink command." 
 
cutlink 7,255,1 
imgdisplay 7 
dislev 7,8,254,255,1 
binscrap 8,8,0,20,0 
binfill 8,9 
162 
binand 9,6,10 
 
write "Circle drawn around inner nuclear membrane marker Part E." 
MBok  "Draw a circle around inner nuclear membrane marker, Part E, at cutlink 
command." 
 
imgdisplay 3 
cutlink 3,255,1 
dislev 3,14,254,255,1 
binscrap 14,14,0,20,0 
binfill 14,15 
binand 15,6,16 
 
write "The computer will draw a circle to define the outer nuclear membrane." 
MBok "The computer will draw a circle to define the outer nuclear membrane, 
Part D"  
 
macro DoThick(Input=1,GreyLev=255,Thick=3,OvColor=12) 
    dislev 3,92,GreyLev,GreyLev 
    bindilate 92,93,7,Thick 
    binfill 92,94 
    binnot 94,94 
    binand 93,94,94 
    Gextract 94,1,255,OvColor 
 
binxor 16,94,17 
 
MSsetprop "REGIONFEAT","AREA,SUMD" 
write "Now we can measure Cytoplasmic Localization, Image 18, Part A" 
MBok "Now we can measure Cytoplasmic Localization, Image 18, Part A" 
! dislev 10,18,1,255,1  
binscrap 18,18,0,20,0 
 
write "Now we can measure Nuclear Membrane Localization, Image 19, Part B" 
MBok  "Now we can measure Nuclear Membrane Localization, Image 19, Part 
B" 
! dislev 17,19,4,255,1  
binscrap 19,19,0,20,0 
 
write "Now we can measure Nuclear Protein Localization, Image 20, Part C" 
MBok "Now we can measure Nuclear Protein Localization, Image 20, Part C" 
! dislev 16,20,4,255,1  
binscrap 20,20,0,20,0 
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MSmeasmask 18,1,"dataR",0,1,10 
MSmeasmask 18,2,"dataG",0,1,10 
MSmeasmask 18,3,"dataB",0,1,10 
 
MSmeasmask 19,1,"dataR",1,1,10 
MSmeasmask 19,2,"dataG",1,1,10 
MSmeasmask 19,3,"dataB",1,1,10 
 
MSmeasmask 20,1,"dataR",1,1,10 
MSmeasmask 20,2,"dataG",1,1,10 
MSmeasmask 20,3,"dataB",1,1,10 
 
MBok  "The first measurement is Part A , 2nd is Part B, 3rd is Part C." 
datalist "dataR",0,0 
pause "Make sure to print out the database!!" 
datalist "dataG",0,0 
pause "Make sure to print out the database!!" 
datalist "dataB",0,0 
pause "Make sure to print out the database!!" 
 
MBok "These next several lines are for creating the 3 circles, pseudo-colored." 
imgnew 100,256,256,1,"Grey" 
Gclear 0 
Gextract 8,254,255,12 
Gextract 14,254,255,14 
Gextract 94,254,255,6 
Gmerge 100,255 
imgdelete 100 
imgnew 100,256,256,1,"Colour" 
Gmerge 95,255 
Gclear 0 
#!imgsetpath "d:\" 
!imgsave 95,"d:\circles.tif" 
#MBok "Try function in line 118 or 119 to give you the best results." 
#combine 95,2,102,1.00,0.82,0  
#add 95,2,101,2  
 
write "Done" 
MBok "Thank you Roger!!!" 
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APPENDIX B 
 
DNA construct information and clone maps 
 
B1:  ∆XbaI, NarI pUC 18. 
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 B2: ∆XbaI, NarI pUC 18 EGFP/Alt. EGFP. 
 
Oligonucleotides for PCR: 
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B3: Sorting Motif clones. 
 
 
Amino acid sequences and Oligonucleotides: 
   M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L  S  N  S  N  N    
E66 ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTATCAAATAGCAATAAT 
 TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATACAAAAAACATGGATAGTTTATCGTTATTA 
 
    K  N  D  A  N  K  N  N  A  F  I  D 
 AAAAATGATGCCAATAAAAACAATGCTTTTATTGAT 
 TTTTTACTACGGTTATTTTTGTTACGAAAATAACTA 
 
           M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L  S  N   
SM1A 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATACAAAAAACATGGATAGTTTA 
 
    S  N  N  K  N  D  A  N  K  N  N   A  G   A   M-EGFP 
 AGCAATAATAAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TCGTTATTATTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  L  L  I  C  L  L  L  L  S  N   
SM1C 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTGTTAATATGTTTGTTGTTGCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAACAATTATACAAACAACAACGATAGTTTA 
 
    S  N  N  K  N  D  A  N  K  N  N   A  G   A   M-EGFP 
 AGCAATAATAAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TCGTTATTATTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L   
SM2A 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTGTTAATATGTTTGTTGTTGCTA 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAACAATTATACAAACAACAACGAT 
 
    K  N  D  A  N  K  N  N   A  G   A   M-EGFP 
 AAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  L  L  I  C  L  L  L  L  
SM2C 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTA 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATACAAAAAACATGGAT 
 
    K  N  D  A  N  K  N  N   A  G   A   M-EGFP 
 AAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
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           M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L  S  N   
SM3A/B 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATACAAAAAACATGGATAGTTTA 
 
    S  N  N   A  G   A   M-EGFP/Alt.EGFP 
 AGCAATAAT gccgg   3’ 
 TCGTTATTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  L  L  I  C  L  L  L  L  S  N   
SM3C/D 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTGTTAATATGTTTGTTGTTGCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAACAATTATACAAACAACAACGATAGTTTA 
 
    S  N  N   A  G   A   M-EGFP/Alt.EGFP 
 AGCAATAAT gccgg   3’ 
 TCGTTATTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L  S  N   
SM4A/B 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATACAAAAAACATGGATAGTTTA 
 
    S  N  N  K  N  D  A  N  K  N  N   A  G   A   M-EGFP/Alt.EGFP 
 AGCAATAATAAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TCGTTATTATTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  L  L  I  C  L  L  L  L   
SM4C/D 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTGTTAATATGTTTGTTGTTGCTA 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAACAATTATACAAACAACAACGAT 
 
    A  G   A   M-EGFP/Alt.EGFP 
 gccgg   3’ 
 cggccgc 5’ 
 
           M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  L  F  L  Y  L  S  N   
∆C SM1A 5’ ctaga ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATTGTTTTTGTACCTATCAAAT 
 3’     t TACAGATAGCATAACTAATAACAGTATCAACATTATAAAAATTATAACAAAAACATGGATAGTTTA 
 
    S  N  N  K  N  D  A  N  K  N  N   A  G   A   M-EGFP 
 AGCAATAATAAAAATGATGCCAATAAAAACAAT gccgg   3’ 
 TCGTTATTATTTTTACTACGGTTATTTTTGTTA cggccgc 5’ 
 
 
 
 
Sorting motif amino acid sequences and corresponding complementary oligonucleotides used 
for construction of the EGFP/Alt. EGFP fusion proteins.  “A” and “B” represent native E66 
sequences, while “C” and “D” have the aromatic amino acid codons (bold text) replaced with a 
leucine codon.  The transmembrane sequences are shown in red. The aromatic amino acids or 
the leucines substituted in their place are bolded.  The polar amino acids are shown in blue.  The 
charged cluster of amino acids is shown in purple. The EGFP of Alt.EGFP sequences are shown 
in green.  In ∆C SM1A, the cystiene to leucine mutation is underlined. 
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B4: E66 Charge Modification of E66. 
 
 
 
Amino acid sequences and Oligonucleotides: 
   M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  L  S  N  S  N  N     
E66 ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTACCTATCAAATAGCAATAAT 
  
    K  N  D  A  N  K  N  N  A  F  I  D 
 AAAAATGATGCCAATAAAAACAATGCTTTTATTGAT 
  
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 GGG FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  G  N  G  A  N  G   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATGGGAATGGGGCCAATGGG AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 AAA FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  A  N  A  A  N  A   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATGCGAATGCGGCCAATGCG AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 KKK FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  K  N  K  A  N  K   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATAAAAATAAAGCCAATAAA AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 DDD FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  D  N  D  A  N  D   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATGATAATGATGCCAATGAT AACAATGCTTTTATTGATCTC   3’ 
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                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 KDA FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  K  N  D  A  N  A   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATAAAAATGATGCCAATGCG AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 ADK FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  A  N  D  A  N  K   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATGCGAATGATGCCAATAAA AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 ADA FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  A  N  D  A  N  A   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATGCGAATGATGCCAATGCG AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 RDR FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  R  N  D  A  N  R   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATCGCAATGATGCCAATCGC AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 KEK FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  K  N  E  A  N  K   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATAAAAATGAAGCCAATAAA AACAATGCTTTTATTGATCTC   3’ 
 
                     M  S  I  V  L  I  I  V  I  V  V  I  F  L  I  C  F  L  Y  
E66 RER FW 5’ cccgagctcggatcc ATGTCTATCGTATTGATTATTGTCATAGTTGTAATATTTTTAATATGTTTTTTGTAC 
  
    L  S  N  S  N  N  R  N  E  A  N  R   N  N  A  F  I  D  L
 CTATCAAATAGCAATAATCGCAATGAAGCCAATCGC AACAATGCTTTTATTGATCTC   3’ 
 
 
E66 RV 5’ CAGATACAAGCCGAGCCAGTAACGGCGGTGAGGACGAGC  3’ 
 
Amino acid sequences and PCR oligonucleotides for the amplification of ODV-E66 with the 
charged a.a.of the sorting motif changed to the noted amino acid.  Text in lowercase denotes 
nucleotides added for cloning purposes, text in uppercase denotes the nucleotides 
corresponding to the E66 sequence, bolded text corresponds to the codons that were changed 
to yield the noted amino acid, and underlined text corresponds to the complementary sequence 
of E66 used the PCR amplification. 
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B5: 125 amino acid Charge Modification of E66 fused to EGFP. 
 
 
 
Amino acid sequence and Oligonucleotides: 
 
         SacII  AflII  XbaI  Kozak  M  S  I   V  L  I  I  V  I  V   
125 new FW 5’ cta ccgcgg cttaag tctaga ccacc atgtctata GTATTGTTATTGGTCATAGTTG 3’  
  
 
            NarI   KpnI   F  D  P   V  S  T  W  P  S                   
125 gfp RV 5’ atctac ggcgcc ggtacc aaagtccgg AACGCTTGTCCACGGACTC 3’ 
 
 
The amino acid sequence and PCR oligonucleotides used for the amplification of the sequence 
corresponding to the first 125 amino acids of E66 with the charge modifications (appendix B5).  
Text in uppercase corresponds to the sequence that is complementary to E66. 
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Appendix B6:  Sorting Motif plus Kozak 
 
 
Amino acid sequence and Oligonucleotide: 
 
         SacII  AflII    PstI    Kozak  M  S  I  V  L  I  I  V  I  V   
125 FW (ori) 5’ cta ccgcgg cttaag t cgatcg t ccacc ATGTCTATTGTATTGTTATTGGTCATAGTTG 3’  
 
The amino acid sequence and PCR oligonucleotides used for the amplification of the SM with a 
5’ Kozak consensus transcription initiation site.  Text in uppercase corresponds to the sequence 
that is complementary to E66. 
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B7: N-terminal deletion of LBR-EGFP clones. 
 
 
 
Oligonucleotides: 
 
 
PCR oligonucleotides for amplification of the coding sequence for LBR EGFP minus the N-
terminal binding domain.  LBR-GFP-F-C is the forward oligonucleotide used to generate the 200-
238LBR-GFP clone construct, LBR-GFP-F-H is the forward oligonucleotide used to generate the 
208-238LBR-GFP clone construct, and LBR-GFP-R is the reverse oligonucleotides used to 
generate both the 200-238LBR-GFP and 208-238LBR-GFP clone constructs.  
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B8: LBR-EGFP Kozak clones. 
 
 
 
Amino acid Sequence and Oligonucleotides: 
 
 
                    BamHI     M  I  R  A  K  D  L 
200-238 LBR-Kozak FW 5’ gcg ggatccacc ATGATTCGGCAAAGGACTTG 3’ 
                        Kozak 
 
           BamHI     M  F  G  G  V  P   
208-238 LBR-Kozak FW 5’ gcg ggatccacc ATGTTTGGAGGAGTACCTG 3’ 
                        Kozak 
 
           BamHI    
EGFP RV NotI                         5’ ata gcgggccgc TTACTTGTACAGCTCGTC 3’ 
 
 
The amino acid sequence and PCR oligonucleotides used for the amplification of 200-238LBR- and 
208-238LBR-GFP with a 5’ Kozak consensus transcription initiation site.  Text in uppercase 
corresponds to the sequence that is complementary to 200-238LBR- and 208-238LBR-GFP. 
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B9: T71-238LBR-EGFP. 
 
 
 
 
 
 
                    BamHI     M  A  S  M  T  G  G  Q  Q  M  E  H  S  H 
1-238 LBR FW T7N 5’ gcg ggatccacc ATGGCTTCTATGACCGGCGGACAGCAGATGGAACATTCACAC 
                        Kozak 
 
                        S  S  R  K  F  A  D 
   CCTAGTAGGAAATTTGCCGAT  3’ 
 
The amino acid sequence and PCR oligonucleotides used for the amplification of 1-238LBR-GFP 
with a N-terminal T7 epitope tag.  Underlined in uppercase corresponds to the sequence that is 
complementary to 1-238LBR-GFP. 
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